Enovis (ENOV) 10-Q31 Oct 192019 Q3 Quarterly reportFinancial data

Company Profile

COVER PAGE

COVER PAGE	9 Months Ended
COVER PAGE	Sep. 27, 2019shares
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 27, 2019
Document Transition Report	false
Entity File Number	001-34045
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	54-1887631
Entity Address, Address Line One	420 National Business Parkway,
Entity Address, Address Line Two	5th Floor
Entity Address, Postal Zip Code	20701
Entity Address, City or Town	Annapolis Junction,
Entity Address, State or Province	MD
City Area Code	(301)
Local Phone Number	323-9000
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	117,756,730
Entity Registrant Name	Colfax CORP
Entity Central Index Key	0001420800
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2019
Amendment Flag	false

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 27, 2019	Sep. 28, 2018	Sep. 27, 2019	Sep. 28, 2018
Income Statement [Abstract]
Revenues	$ 846,519	$ 524,022	$ 2,439,085	$ 1,618,152
Cost of sales	478,377	352,749	1,433,872	1,070,371
Gross profit	368,142	171,273	1,005,213	547,781
Selling, general and administrative expense	290,500	129,558	846,288	403,370
Restructuring and other related charges	9,781	6,659	47,197	19,643
Operating income	67,861	35,056	111,728	124,768
Pension settlement loss	33,616	0	33,616	0
Interest expense, net	31,828	11,611	86,820	33,455
Loss on short-term investments	0	0	0	10,128
Income (loss) from continuing operations before income taxes	2,417	23,445	(8,708)	81,185
Provision (benefit) for income taxes	(1,353)	6,787	6,840	(4,076)
Net income (loss) from continuing operations	3,770	16,658	(15,548)	85,261
Income (loss) from discontinued operations, net of taxes	9,024	18,544	(486,265)	20,762
Net income (loss)	12,794	35,202	(501,813)	106,023
Less: income attributable to noncontrolling interest, net of taxes	2,320	3,892	8,970	11,721
Net income (loss) attributable to Colfax Corporation	$ 10,474	$ 31,310	$ (510,783)	$ 94,302
Net income (loss) per share - basic
Continuing operations	$ 0.02	$ 0.14	$ (0.14)	$ 0.69
Discontinued operations	0.06	0.13	(3.63)	0.09
Consolidated operations	0.08	0.27	(3.77)	0.78
Net income (loss) per share - diluted
Continuing operations	0.02	0.14	(0.14)	0.69
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share	0.06	0.13	(3.63)	0.09
Earnings Per Share, Diluted	$ 0.08	$ 0.26	$ (3.77)	$ 0.77

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 27, 2019	Sep. 28, 2018	Sep. 27, 2019	Sep. 28, 2018
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 12,794	$ 35,202	$ (501,813)	$ 106,023
Other comprehensive (loss) income:
Foreign currency translation, net of tax of $1,787, $(2,689), $1,375 and $1,880, respectively	(135,157)	(46,437)	(128,620)	(187,235)
Unrealized gain on hedging activities, net of tax of $4,411, $252, $4,102 and $3,352, respectively	11,757	136	13,413	7,156
Amounts reclassified from Accumulated other comprehensive income:
Amortization of pension and other post-retirement net actuarial gain (loss), net of tax of $(5,960), $165, $(7,679) and $641, respectively	(12,206)	670	(21,166)	2,503
Amortization of pension and other post-retirement prior service cost	0	1	32	2
Other comprehensive loss	(135,606)	(45,630)	(136,341)	(177,574)
Comprehensive loss	(122,812)	(10,428)	(638,154)	(71,551)
Less: comprehensive (loss) income attributable to noncontrolling interest	(3,384)	(4,524)	5,272	(9,483)
Comprehensive loss attributable to Colfax Corporation	$ (119,428)	$ (5,904)	$ (643,426)	$ (62,068)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) [Parenthetical] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 27, 2019	Sep. 28, 2018	Sep. 27, 2019	Sep. 28, 2018
Statement of Comprehensive Income [Abstract]
Foreign currency translation, tax	$ 1,787	$ (2,689)	$ 1,375	$ 1,880
Unrealized gain on hedging activities, tax	4,411	252	4,102	3,352
Amortization of pension and other post-retirement net actuarial loss, tax	(5,960)	165	(7,679)	641
Amortization of pension and other post-retirement prior service cost, tax	$ 0	$ 0	$ 0	$ 0

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 27, 2019	Dec. 31, 2018
ASSETS
Cash and cash equivalents	$ 127,065	$ 77,153
Trade receivables, less allowance for doubtful accounts of $40,864 and $26,844	576,139	386,588
Inventories, net	584,351	359,655
Other current assets	198,232	137,801
Current portion of assets held for sale	2,013,345	997,244
Total current assets	3,499,132	1,958,441
Property, plant and equipment, net	478,806	327,155
Goodwill	2,784,249	1,497,832
Intangible assets, net	2,262,377	628,300
Lease asset - right of use	159,999	0
Other assets	406,709	463,525
Assets held for sale, less current portion	0	1,740,705
Total assets	9,591,272	6,615,958
LIABILITIES AND EQUITY
Current portion of long-term debt	29,654	5,020
Accounts payable	376,406	291,233
Customer advances and billings in excess of costs incurred	16,566	16,827
Accrued liabilities	431,333	274,017
Current portion of liabilities held for sale	651,718	612,248
Total current liabilities	1,505,677	1,199,345
Long-term debt, less current portion	4,002,365	1,192,408
Non-current lease liability	123,238	0
Other liabilities	827,054	651,864
Liabilities held for sale, less current portion	0	95,395
Total liabilities	6,458,334	3,139,012
Equity:
Common stock, $0.001 par value; 400,000,000 shares authorized; 117,756,730 and 117,275,217 issued and outstanding	118	117
Additional paid-in capital	3,434,617	3,057,982
Retained earnings	496,423	991,838
Accumulated other comprehensive loss	(949,150)	(780,177)
Total Colfax Corporation equity	2,982,008	3,269,760
Noncontrolling interest	150,930	207,186
Total equity	3,132,938	3,476,946
Total liabilities and equity	$ 9,591,272	$ 6,615,958

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] - USD ($) $ in Thousands	Sep. 27, 2019	Dec. 31, 2018
Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]
Trade receivables, allowance for doubtful accounts	$ 40,864	$ 26,844
Common Stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common Stock, Shares Authorized	400,000,000	400,000,000
Common Stock, Shares, Issued	117,756,730	117,275,217
Common Stock, Shares, Outstanding	117,756,730	117,275,217

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENT OF EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Noncontrolling Interest
Cumulative effect of accounting change				$ 5,152	$ (5,152)
Shares, Outstanding at Dec. 31, 2017		123,245,827
Balance at Dec. 31, 2017	$ 3,727,264	$ 123	$ 3,228,174	846,490	(574,372)	$ 226,849
Net (loss) income	29,042			24,535		4,507
Distributions to noncontrolling owners	(721)					(721)
Other comprehensive loss, net of tax	77,499				71,447	6,052
Common stock-based award activity (in shares)		231,908
Common stock-based award activity	8,160		8,160
Shares, Outstanding at Mar. 30, 2018		123,477,735
Balance at Mar. 30, 2018	3,841,244	$ 123	3,236,334	876,177	(508,077)	236,687
Shares, Outstanding at Dec. 31, 2017		123,245,827
Balance at Dec. 31, 2017	3,727,264	$ 123	3,228,174	846,490	(574,372)	226,849
Net (loss) income	106,023
Other comprehensive loss, net of tax	(177,574)
Shares, Outstanding at Sep. 28, 2018		117,199,449
Balance at Sep. 28, 2018	3,478,322	$ 117	3,051,695	945,944	(735,894)	216,460
Shares, Outstanding at Mar. 30, 2018		123,477,735
Balance at Mar. 30, 2018	3,841,244	$ 123	3,236,334	876,177	(508,077)	236,687
Net (loss) income	41,779			38,457		3,322
Distributions to noncontrolling owners	(3)					(3)
Other comprehensive loss, net of tax	(209,443)				(190,603)	(18,840)
Common stock repurchases, shares		(4,604,974)
Common stock repurchases	(143,902)	$ (4)	(143,898)
Common stock-based award activity (in shares)		53,153
Common stock-based award activity	7,765		7,765
Shares, Outstanding at Jun. 29, 2018		118,925,914
Balance at Jun. 29, 2018	3,537,440	$ 119	3,100,201	914,634	(698,680)	221,166
Net (loss) income	35,202			31,310		3,892
Distributions to noncontrolling owners	(182)					(182)
Other comprehensive loss, net of tax	(45,630)				(37,214)	(8,416)
Common stock repurchases, shares		(1,844,451)
Common stock repurchases	(56,098)	$ (2)	(56,096)
Common stock-based award activity (in shares)		117,986
Common stock-based award activity	7,590		7,590
Shares, Outstanding at Sep. 28, 2018		117,199,449
Balance at Sep. 28, 2018	3,478,322	$ 117	3,051,695	945,944	(735,894)	216,460
Cumulative effect of accounting change				15,368	(15,368)
Shares, Outstanding at Dec. 31, 2018		117,275,217
Balance at Dec. 31, 2018	3,476,946	$ 117	3,057,982	991,838	(780,177)	207,186
Net (loss) income	(48,002)			(52,023)		4,021
Distributions to noncontrolling owners	(2,170)					(2,170)
Noncontrolling interest share repurchase	(92,721)		(22,409)		(21,372)	(48,940)
Other comprehensive loss, net of tax	22,172				18,053	4,119
Issuance of Tangible Equity Units	377,814		377,814
Common stock-based award activity (in shares)		283,197
Common stock-based award activity	7,677	$ 1	7,676
Shares, Outstanding at Mar. 29, 2019		117,558,414
Balance at Mar. 29, 2019	3,741,716	$ 118	3,421,063	955,183	(798,864)	164,216
Shares, Outstanding at Dec. 31, 2018		117,275,217
Balance at Dec. 31, 2018	3,476,946	$ 117	3,057,982	991,838	(780,177)	207,186
Net (loss) income	(501,813)
Other comprehensive loss, net of tax	(136,341)
Shares, Outstanding at Sep. 27, 2019		117,756,730
Balance at Sep. 27, 2019	3,132,938	$ 118	3,434,617	496,423	(949,150)	150,930
Shares, Outstanding at Mar. 29, 2019		117,558,414
Balance at Mar. 29, 2019	3,741,716	$ 118	3,421,063	955,183	(798,864)	164,216
Net (loss) income	(466,605)			(469,234)		2,629
Distributions to noncontrolling owners	(2,970)					(2,970)
Noncontrolling interest share repurchase	(366)		(565)		410	(211)
Other comprehensive loss, net of tax	(22,907)				(20,794)	(2,113)
Common stock-based award activity (in shares)		108,945
Common stock-based award activity	7,481		7,481
Shares, Outstanding at Jun. 28, 2019		117,667,359
Balance at Jun. 28, 2019	3,256,349	$ 118	3,427,979	485,949	(819,248)	161,551
Net (loss) income	12,794			10,474		2,320
Distributions to noncontrolling owners	(7,237)					(7,237)
Other comprehensive loss, net of tax	(135,606)				(129,902)	(5,704)
Common stock-based award activity (in shares)		89,371
Common stock-based award activity	6,638		6,638
Shares, Outstanding at Sep. 27, 2019		117,756,730
Balance at Sep. 27, 2019	$ 3,132,938	$ 118	$ 3,434,617	$ 496,423	$ (949,150)	$ 150,930

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENT OF EQUITY Statement of Stockholders' Equity [Parenthetical] - USD ($) $ in Thousands	3 Months Ended
	Sep. 27, 2019	Jun. 28, 2019	Mar. 29, 2019	Sep. 28, 2018	Jun. 29, 2018	Mar. 30, 2018
Statement of Stockholders' Equity [Parenthetical] [Abstract]
Cumulative effect of accounting change, tax						$ 2,808
Other comprehensive income, tax	$ 193	$ (1,981)	$ (413)	$ (2,272)	$ 11,718	$ (3,573)

CONDENSED CONSOLIDATED STATEM_6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 27, 2019	Sep. 28, 2018
Statement of Cash Flows [Abstract]
Net income	$ (501,813)	$ 106,023
Adjustments to reconcile net income to net cash provided by operating activities:
Held for sale impairment loss	481,000	0
Depreciation, amortization and other impairment charges	190,577	110,597
Stock-based compensation expense	17,005	18,867
Non-cash interest expense	5,674	3,332
Loss on short-term investments	0	10,128
Deferred income tax benefit	(18,673)	(21,730)
Gain on sale of property, plant and equipment	(140)	(8,211)
Loss on sale of business	0	4,337
Pension settlement loss	77,390	0
Changes in operating assets and liabilities:
Trade receivables, net	29,071	(51,722)
Inventories, net	(54,256)	(56,951)
Accounts payable	(98,920)	6,486
Increase (Decrease) in Income Taxes Payable	(39,909)	(12,019)
Customer advances and billings in excess of costs incurred	33,149	18,970
Changes in other operating assets and liabilities	(54,406)	(27,299)
Net cash provided by operating activities	65,749	100,808
Cash flows from investing activities:
Purchases of property, plant and equipment	(100,383)	(40,247)
Proceeds from sale of property, plant and equipment	7,474	17,758
Acquisitions, net of cash received	(3,136,777)	(83,846)
Sale of short-term investments, net	0	139,480
Proceeds from sale of business, net	0	18,626
Net cash (used in) provided by investing activities	(3,229,686)	51,771
Cash flows from financing activities:
Payments under term credit facility	(533,437)	(93,750)
Proceeds from borrowings under notes and term credit facility	2,725,000	0
Proceeds from borrowings on revolving credit facilities and other	1,780,085	911,772
Repayments of borrowings on revolving credit facilities and other	(1,136,186)	(722,573)
Payment of debt issuance costs	(24,402)	0
Proceeds from tangible equity units, net	377,814	0
Proceeds from issuance of common stock, net	4,787	4,648
Payment for noncontrolling interest share repurchase	93,087	0
Payment for noncontrolling interest share repurchase	0	(200,000)
Other	(9,680)	(1,038)
Net cash provided by (used in) financing activities	3,090,894	(100,941)
Effect of foreign exchange rates on Cash and cash equivalents	(5,216)	(27,757)
(Decrease) increase in Cash and cash equivalents	(78,259)	23,881
Cash and cash equivalents, beginning of period	245,019	262,019
Cash and cash equivalents, end of period	$ 166,760	$ 285,900

General (Text Block)

General (Text Block)	9 Months Ended
General (Text Block)	Sep. 27, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	General Colfax Corporation (the “Company” or “Colfax”) is a leading diversified technology company that provides air and gas handling, fabrication technology, and medical device products and services to customers around the world under the Howden, ESAB, and DJO brands. On May 15, 2019 , the Company entered into a definitive equity and asset purchase agreement (the “Purchase Agreement”) with Granite Holdings US Acquisition Co., a Delaware corporation, and Brillant 3047, GmbH, a company organized under the laws of Germany (collectively, the “Purchaser”), which are affiliates of KPS Capital Partners, LP (“KPS”), pursuant to which the Purchaser agreed to purchase certain subsidiaries and assets comprising Colfax’s Air and Gas Handling business. On September 30, 2019, Colfax completed the sale of its Air and Gas Handling business to the Purchaser for an aggregate purchase price of $1.8 billion , including $1.67 billion of cash paid at closing, subject to certain adjustments pursuant to the Purchase Agreement, and the assumption of certain liabilities and minority interests. Accordingly, the accompanying Condensed Consolidated Financial Statements for all periods presented reflect the Air and Gas Handling business as a discontinued operation. See Note 3, “Discontinued Operations”, for further information. On February 22, 2019 , Colfax completed the purchase of DJO Global, Inc. (“DJO”) pursuant to the previously disclosed Agreement and Plan of Merger (the “Merger Agreement”), dated November 19, 2018 . Colfax paid an aggregate purchase price of $3.15 billion , subject to certain adjustments set forth in the Merger Agreement (the “Purchase Price”). DJO is a global leader in orthopedic solutions, providing orthopedic devices, reconstructive implants, software and services spanning the full continuum of patient care, from injury prevention to rehabilitation. On December 11, 2017, the Company completed the sale of its Fluid Handling business (“Fluid Handling”). Accordingly, the accompanying Condensed Consolidated Financial Statements for all periods presented reflect the Fluid Handling business and the remaining asbestos and environmental activity as a discontinued operation. See Note 3, “Discontinued Operations”, for further information. The Condensed Consolidated Financial Statements included in this quarterly report have been prepared by the Company in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements. The Condensed Consolidated Balance Sheet as of December 31, 2018 is derived from the Company’s audited financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted in accordance with the SEC’s rules and regulations for interim financial statements. The Condensed Consolidated Financial Statements included herein should be read in conjunction with the audited financial statements and related footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 (the “ 2018 Form 10-K”), filed with the SEC on February 21, 2019 . The Condensed Consolidated Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Intercompany transactions and accounts are eliminated in consolidation. The Company makes certain estimates and assumptions in preparing its Condensed Consolidated Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from those estimates. The results of operations for the three and nine months ended September 27, 2019 are not necessarily indicative of the results of operations that may be achieved for the full year. Quarterly results are affected by seasonal variations in the Company’s businesses, and European operations typically experience a slowdown during the July, August and December holiday seasons. General economic conditions may, however, impact future seasonal variations.

Recently Issued Accounting Pron

Recently Issued Accounting Pronouncements (Text Block)	9 Months Ended
Recently Issued Accounting Pronouncements (Text Block)	Sep. 27, 2019
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Pronouncements Accounting Guidance Implemented in 2019 Standards Adopted Description Effective Date ASU 2016-02, Leases (Topic 842) The standard requires a lessee to recognize assets and liabilities associated with the rights and obligations attributable to most leases but also recognize expenses similar to current lease accounting. The standard also requires certain qualitative and quantitative disclosures designed to assess the amount, timing and uncertainty of cash flows arising from leases, along with additional key information about leasing arrangements. The Company adopted ASU No. 2016-02, “Leases (Topic 842)”, as of January 1, 2019, using the modified retrospective approach. The modified retrospective approach provides a method for recording existing leases at adoption and in comparative periods that approximates the results of a full retrospective approach without restating prior periods. In addition, the Company elected the package of practical expedients permitted under the transition guidance within the standard, which among other things, allowed historical lease classification to be carried forward. Additionally, the Company elected the practical expedient to consolidate less significant non-lease components into the lease component for all asset classes. The Company made an accounting policy election, as permitted by Topic 842 to only record a right-of-use asset and related liability for leases with an initial term in excess of 12 months. The Company recognizes those lease payments in the Consolidated Statement of Operations on a straight-line basis over the lease term. The Company has recognized a right-of-use asset of $160 million, with corresponding related lease liabilities on the Condensed Consolidated Balance Sheet. For more information, refer to Note 10, “Leases”. January 1, 2019 ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income The standard provides entities the option to reclassify to retained earnings the tax effects resulting from the U.S. Tax Cuts and Jobs Act of 2017 (the “Tax Act”) related to items stranded in accumulated other comprehensive income. The guidance was applied retrospectively as of January 1, 2019. As a result of this accounting guidance, $15.4 million of tax benefit formerly booked to Other Comprehensive Income was reclassified to retained earnings. January 1, 2019 New Accounting Guidance to be Implemented Standards Pending Adoption Description Anticipated Impact Effective/Adoption Date ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments The ASU eliminates the probable initial recognition threshold under current GAAP and broadens the information an entity must consider when developing its expected credit loss estimates to include forward-looking information. The standard applies to most financial assets held at amortized costs, as well as certain other instruments. Under the current expected credit loss (CECL) model, entities must estimate losses over the entire contractual term of the asset from the date of initial recognition. In determining expected losses, consideration must be given to historical loss experience, current conditions, and reasonable and supportable forecasts incorporating forward looking information. The Company notes that certain financial assets, which are not reserved for currently, are now in the scope of this ASU. The Company has selected a compliant methodology and is in the process of performing a quantitative assessment of the materiality of the adoption of this ASU. The Company does not intend to early adopt this new guidance. January 1, 2020 ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement The ASU modifies the disclosure requirements for fair value measurements. This accounting standard update impacts disclosures only. The Company is currently evaluating the impact of this ASU on its consolidated financial statement disclosures and the timing of adoption. January 1, 2020 ASU 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Topic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans The ASU modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. This accounting standard update impacts disclosures only. The Company is currently evaluating the impact of this ASU on its consolidated financial statement disclosures and the timing of adoption. January 1, 2021

Discontinued Operations (Notes)

Discontinued Operations (Notes)	9 Months Ended
Discontinued Operations (Notes)	Sep. 27, 2019
Discontinued Operations [Abstract]
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]	Discontinued Operations Sale of Air and Gas Handling Business As discussed previously in Note 1, “General,” the Company entered into the Purchase Agreement to sell its Air and Gas Handling business to the Purchaser, and the sale subsequently closed in the Company’s fiscal fourth quarter on September 30, 2019. The accounting requirements for reporting a business to be divested as a discontinued operation were met as of the end of the second quarter of 2019. Accordingly, the accompanying Condensed Consolidated Financial Statements for all periods presented reflect the Air and Gas Handling business as a discontinued operation. The Air and Gas Handling business had revenues of $998.8 million for the nine months ended September 27, 2019 and $1,473.7 million for the year ended December 31, 2018 . The total consideration for the sale was $1.8 billion , including $1.67 billion in cash paid at closing, subject to certain adjustments pursuant to the purchase agreement, and the assumption of certain liabilities and minority interests. Based on the purchase price and the carrying value of the net assets being sold, the Company recorded an impairment loss of $481 million in the second quarter of 2019, which is included in Loss from discontinued operations, net of taxes in the Condensed Consolidated Statement of Operations. The impairment loss included a $449 million goodwill impairment charge and a $32 million valuation allowance charge on assets held for sale relating to the initial estimated cost to sell the business. An accumulated other comprehensive loss of approximately $350 million associated with the Air and Gas Handling business was included in the determination of the goodwill impairment charge, which is mostly attributable to the recognition of cumulative foreign currency translation effects from the long-term strengthening of the U.S. Dollar. The Company reduced the valuation allowance by $8.5 million for amounts paid during the third quarter of 2019. As of September 27, 2019 , the remaining valuation allowance for the estimated cost to sell the disposal group was $23.5 million . The Company also performed an impairment assessment of the assets held for sale as of September 27, 2019 and concluded there was no further impairment. In connection with the Purchase Agreement, the Company and KPS entered into various agreements to provide a framework for their relationship after the disposition, including a transition services agreement. The amounts to be billed for future transition services under the above agreements is not expected to be material to the Company’s results of operations. The key components of Income (loss) from discontinued operations, net of taxes related to the Air and Gas Handling business for the three and nine months ended September 27, 2019 and September 28, 2018 were as follows: Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (In thousands) Net sales $ 338,885 $ 351,351 $ 998,793 $ 1,063,434 Cost of sales 230,692 251,695 689,004 782,232 Selling, general and administrative expense 65,117 65,275 194,562 196,766 Restructuring and other related charges 4,987 9,257 13,354 21,148 Held for sale impairment loss — — 481,000 — Divestiture-related expense (1) 4,481 — 11,692 — Operating income (loss) 33,608 25,124 (390,819 ) 63,288 Interest expense (income) (2) 12,779 (1,726 ) 38,899 (4,302 ) Pension settlement loss — — 43,774 — Income (loss) from discontinued operations before income taxes 20,829 26,850 (473,492 ) 67,590 Income tax expense 9,809 5,610 5,387 15,566 Income (loss) from discontinued operations, net of taxes $ 11,020 $ 21,240 $ (478,879 ) $ 52,024 (1) Primarily related to professional and consulting fees associated with the divestiture including seller due diligence and preparation of regulatory filings, as well as other disposition-related activities. (2) The Company reclassified the portion of its interest expense associated with its Term Loan Facilities that is associated with the mandatory repayment using net proceeds from the sale of the business. Total income attributable to noncontrolling interest related to the Air and Gas Handling business, net of taxes was $1.5 million , $3.5 million , $5.9 million , and $10.0 million for the three months ended September 27, 2019 and September 28, 2018 and the nine months ended September 27, 2019 and September 28, 2018 , respectively. The following table summarizes the major classes of assets and liabilities held for sale that were included in the Company’s consolidated balance sheets as of September 27, 2019 and December 31, 2018 : September 27, 2019 December 31, 2018 (In thousands) ASSETS HELD FOR SALE Cash and cash equivalents $ 39,695 $ 167,866 Trade receivables, less allowance for doubtful accounts of $8,783 and $8,308 520,379 602,830 Inventories, net 155,877 136,880 Other current assets 61,079 89,668 Property, plant, and equipment, net 184,035 176,189 Goodwill 599,544 1,078,785 Intangible assets, net 365,728 384,613 Other assets 110,508 101,118 Valuation allowance on assets held for sale (23,500 ) — Total assets held for sale 2,013,345 2,737,949 Less: current portion 2,013,345 997,244 Total assets held for sale, less current portion $ — $ 1,740,705 LIABILITIES HELD FOR SALE Current portion of long-term debt $ 1,137 $ 1,314 Accounts payable 256,955 349,434 Customer advances and billings in excess of costs incurred 158,324 130,480 Accrued liabilities 140,354 131,020 Other liabilities 94,948 95,395 Total liabilities held for sale 651,718 707,643 Less: current portion 651,718 612,248 Total liabilities held for sale, less current portion $ — $ 95,395 Cash provided by operating activities of discontinued operations related to the sale of the Air and Gas Handling business for the nine months ended September 27, 2019 and September 28, 2018 was $18.0 million and $71.7 million , respectively. Cash used in investing activities of discontinued operations related to the sale of the Air and Gas Handling business was $27.5 million and $35.3 million for the nine months ended September 27, 2019 and September 28, 2018 , respectively. Sale of Fluid Handling Business The Company sold its Fluid Handling business to CIRCOR International, Inc. (“CIRCOR”) on December 11, 2017. After certain post-closing adjustments, total consideration for the sale was $860.6 million , consisting of $551.0 million of cash, 3.3 million shares of CIRCOR common stock (“CIRCOR Shares”), and assumption of $168.0 million of net retirement liabilities. All cash consideration was collected as of June 29, 2018. During the second quarter of 2018, the Company sold its CIRCOR Shares for $139.5 million , net of $5.8 million of underwriters' fees. The related loss of $10.1 million on the disposition of the shares was recorded in Loss on short-term investments in the Consolidated Statements of Operations for the nine months ended September 28, 2018 and was reflected in the Company’s continuing operations. The key components of Loss from discontinued operations related to the Fluid Handling business for the three and nine months ended September 27, 2019 and September 28, 2018 were as follows: Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (In thousands) Selling, general and administrative expense (1) $ 2,637 $ 2,668 $ 7,645 $ 7,262 Divestiture-related expense, net (2) — 1,013 — 3,371 Operating loss (2,637 ) (3,681 ) (7,645 ) (10,633 ) Loss on disposal — — — (4,337 ) Loss from discontinued operations before income taxes (2,637 ) (3,681 ) (7,645 ) (14,970 ) Income tax (benefit) expense (3) (641 ) (985 ) (259 ) 16,292 Loss from discontinued operations, net of taxes $ (1,996 ) $ (2,696 ) $ (7,386 ) $ (31,262 ) (1) Pursuant to the purchase agreement, the Company retained its asbestos-related contingencies and insurance coverages. However, as the Company did not retain an interest in the ongoing operations of the business subject to the contingencies, the Company has classified asbestos-related activity in its Condensed Consolidated Statements of Operations as part of Loss from discontinued operations. See Note 15, “Commitments and Contingencies” for further information. (2) Primarily related to professional and consulting fees associated with the divestiture including due diligence and preparation of regulatory filings, as well as employee benefit arrangements and other disposition-related activities. (3) Income tax expense for the nine months ended September 28, 2018 includes incremental tax expense due to changes in the estimated gain allocation by jurisdiction which was recognized during the three months ended June 29, 2018. The Company did not have material cash flows for discontinued operations related to the sale of the Fluid Handling business during the nine months ended September 27, 2019 and September 28, 2018 .

Acquisitions Acquisitions (Note

Acquisitions Acquisitions (Notes)	9 Months Ended
Acquisitions Acquisitions (Notes)	Sep. 27, 2019
Business Combinations [Abstract]
Business Combination Disclosure [Text Block]	Acquisition On February 22, 2019 , Colfax completed the purchase of DJO Global, Inc. (“DJO”) pursuant to the previously disclosed Agreement and Plan of Merger (the “Merger Agreement”), dated November 19, 2018 . Colfax paid an aggregate net purchase price of $3.15 billion , subject to certain adjustments set forth in the Merger Agreement (the “Purchase Price”). See Note 8, “Equity” and Note 11, “Debt” for a discussion of the respective financing components of the DJO acquisition. DJO is a global leader in orthopedic solutions, providing orthopedic devices, reconstructive implants, software and services spanning the full continuum of patient care, from injury prevention to rehabilitation. DJO has approximately 5,000 employees across 18 locations around the world. The acquisition is expected to evolve the Company to higher margins, faster growth, and lower cyclicality, while providing opportunities for significant bolt-on and adjacent acquisitions over time. The value included as Goodwill for this acquisition is reflective of these expected benefits in conjunction with anticipated synergies as the Company uses Colfax Business System (“CBS”) to drive further operating improvement, margin expansion, and long-term growth. CBS is the Company’s business management system, combining a comprehensive set of tools and repeatable, teachable processes, that the Company uses to create superior value for its customers, shareholders and associates. During the three and nine months ended September 27, 2019 , the Company incurred $0.7 million and $56.7 million , respectively, of advisory, legal, audit, valuation and other professional service fees in connection with the DJO acquisition, which are included in Selling, general and administrative expense in the Condensed Consolidated Statement of Operations. As of September 27, 2019 , there was $0.8 million related to these expenses included in Accrued liabilities in the Condensed Consolidated Balance Sheet. The DJO acquisition was accounted for using the acquisition method of accounting and accordingly, the Condensed Consolidated Financial Statements include the financial position and results of operations from the date of acquisition. The following unaudited proforma financial information presents Colfax’s consolidated financial information assuming the acquisition had taken place on January 1, 2018. These amounts are presented in accordance with GAAP, consistent with the Company’s accounting policies. Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (Unaudited, in thousands) Net sales $ 846,519 $ 818,073 $ 2,608,251 $ 2,509,669 Net income (loss) from continuing operations attributable to Colfax Corporation 7,676 (3,025 ) 72,857 39,582 The following table summarizes the Company’s current estimate of the aggregate fair value of the assets acquired and liabilities assumed at the date of acquisition. These amounts, including inventories, deferred taxes, intangible assets, useful lives of the intangible assets, and property, plant and equipment, are determined based upon certain valuations and studies that have yet to be finalized. Accordingly, the assets acquired and liabilities assumed, as detailed below, are subject to adjustment once the detailed analyses are completed, which could be material. Substantially all of the Goodwill recognized is not expected to be deductible for income tax purposes. February 22, 2019 (In thousands) Trade receivables $ 160,234 Inventories 208,619 Property, plant and equipment 170,601 Goodwill 1,301,451 Intangible assets 1,737,000 Accounts payable (108,540 ) Other assets and liabilities, net (337,402 ) Total 3,131,963 Less: net assets attributable to noncontrolling interest (1,861 ) Consideration, net of cash acquired $ 3,130,102 The following table summarizes preliminary Intangible assets acquired, excluding Goodwill, as of February 22, 2019: Intangible Asset Weighted-Average Amortization Period (In thousands) (Years) Trademarks $ 479,000 16 Customer relationships 954,000 14 Acquired technology 304,000 12 Intangible assets $ 1,737,000

Revenue (Notes)

Revenue (Notes)	9 Months Ended
Revenue (Notes)	Sep. 27, 2019
Revenue Recognition, Milestone Method [Line Items]
Revenue from Contract with Customer [Text Block]	Revenue The Company’s Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment. Substantially all revenue from the Fabrication Technology business is recognized at a point in time. The Company disaggregates its Fabrication Technology revenue into the following product groups: Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (In thousands) Equipment $ 162,531 $ 143,130 $ 525,148 $ 441,994 Consumables 376,697 380,892 1,167,199 1,176,158 Total $ 539,228 $ 524,022 $ 1,692,347 $ 1,618,152 Contracts with customers in the consumables product grouping generally have a shorter fulfillment period than equipment contracts. The Company’s Medical Technology segment provides products and services spanning the full continuum of patient care, from injury prevention to rehabilitation. The Company’s Medical Technology sales are primarily derived from three sales channels including dealers and distributors, insurance, and direct to consumers and hospitals. Substantially all its revenue from the Medical Technology business is recognized at a point in time. The Company disaggregates its Medical Technology revenue into the following product groups: Three Months Ended September 27, 2019 Nine Months Ended September 27, 2019 (In thousands) Prevention & Rehabilitation $ 221,314 $ 533,986 Reconstructive 85,977 212,752 Total $ 307,291 $ 746,738 Given the nature of the Fabrication Technology and Medical Technology businesses, the total amount of unsatisfied performance obligations with an original contract duration of greater than one year as of September 27, 2019 is immaterial. The nature of the Company’s contracts gives rise to certain types of variable consideration, including rebates, implicit price concessions, and other discounts. The Company includes estimated amounts of variable consideration in the transaction price to the extent that it is probable there will not be a significant reversal of revenue. In some circumstances for both over-time and point-in-time contracts, customers are billed in advance of revenue recognition, resulting in contract liabilities. As of December 31, 2018 and 2017 , total contract liabilities were $13.0 million and $17.3 million , respectively. During the three and nine months ended September 27, 2019 , revenue recognized that was included in the contract liability balance at the beginning of the year was $4.8 million and $13.0 million , respectively. During the three and nine months ended September 28, 2018 , revenue recognized that was included in the contract liability balance at the beginning of the year was $0.9 million and $17.3 million , respectively. As of September 27, 2019 and September 28, 2018 , total contract liabilities were $15.6 million and $19.5 million

Net Income Per Share (Text Bloc

Net Income Per Share (Text Block)	9 Months Ended
Net Income Per Share (Text Block)	Sep. 27, 2019
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	Net Income (Loss) Per Share from Continuing Operations Net income (loss) per share from continuing operations was computed as follows: Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (In thousands, except share data) Computation of Net income (loss) per share from continuing operations: Net income (loss) from continuing operations attributable to Colfax Corporation (1) $ 2,901 $ 16,231 $ (18,636 ) $ 83,520 Weighted-average shares of Common stock outstanding - basic 136,121,017 117,709,725 135,440,566 121,283,339 Net income (loss) per share from continuing operations - basic $ 0.02 $ 0.14 $ (0.14 ) $ 0.69 Computation of Net income (loss) per share from continuing operations - diluted: Net income (loss) from continuing operations attributable to Colfax Corporation (1) $ 2,901 $ 16,231 $ (18,636 ) $ 83,520 Weighted-average shares of Common stock outstanding - basic 136,121,017 117,709,725 135,440,566 121,283,339 Net effect of potentially dilutive securities - stock options and restricted stock units 929,143 747,211 — 518,179 Weighted-average shares of Common stock outstanding - diluted 137,050,160 118,456,936 135,440,566 121,801,518 Net income (loss) per share from continuing operations - diluted $ 0.02 $ 0.14 $ (0.14 ) $ 0.69 (1) Net income (loss) from continuing operations attributable to Colfax Corporation for the respective periods is calculated using Net income (loss) from continuing operations less the continuing operations component of the income attributable to noncontrolling interest, net of taxes of $0.9 million and $3.1 million for the three and nine months ended September 27, 2019 and $0.4 million and $1.7 million for the three and nine months ended September 28, 2018 , respectively. For the three and nine months ended September 27, 2019 , the weighted-average shares of Common stock outstanding - basic includes the impact of 18.4 million shares related to the issuance of Colfax’s tangible equity units. See Note 8, “Equity” for details. The weighted-average computation of the dilutive effect of potentially issuable shares of Common stock under the treasury stock method for the three and nine months ended September 27, 2019 excludes 4.4 million and 4.6 million , respectively, of outstanding stock-based compensation awards as their inclusion would be anti-dilutive. The weighted-average computation of the dilutive effect of potentially issuable shares of Common stock under the treasury stock method for the three and nine months ended September 28, 2018 excludes 3.5 million of outstanding stock-based compensation awards as their inclusion would be anti-dilutive.

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Sep. 27, 2019
Income Tax Disclosure [Abstract]
Income Taxes	During the three and nine months ended September 27, 2019 , Income (loss) from continuing operations before income taxes was $2.4 million and $(8.7) million , respectively, while the income tax (benefit) provision was $(1.4) million and $6.8 million , respectively. The effective tax rates were (56.0)% and (78.5)% for the three and nine months ended September 27, 2019 , respectively. The effective tax rate for the three months ended September 27, 2019 differed from the 2019 U.S. federal statutory rate of 21% mainly due to a discrete tax benefit associated with the enactment of tax law changes in a European jurisdiction offset in part by losses in certain jurisdictions where a tax benefit is not expected to be recognized in 2019 , and non-deductible deal costs. The effective tax rate for the nine months ended September 27, 2019 differed from the 2019 U.S. federal statutory rate of 21% mainly due to losses in certain jurisdictions where a tax benefit is not expected to be recognized in 2019 , $16.7 million of non-deductible deal costs, and an aggregate $9.2 million unfavorable discrete U.S. income tax expense due to a change in valuation allowance and state tax expense as a result of the DJO acquisition, offset in part by a discrete tax benefit associated with the enactment of tax law changes in a European jurisdiction. During the three and nine months ended September 28, 2018 , Income from continuing operations before income taxes was $23.4 million and $81.2 million , respectively, while the income tax provision (benefit) was $6.8 million and $(4.1) million , respectively. The effective tax rates were 28.9% and (5.0)% for the three and nine months ended September 28, 2018 , respectively. The effective tax rate for the three months ended September 28, 2018 differs from the 2018 U.S. federal statutory rate of 21% mainly due to losses in certain tax jurisdictions where a tax benefit is not expected to be realized in 2018, the net impact of foreign earnings taxed at a higher rate offset in part by the expected realization of U.S. tax credits. The effective tax rate for the nine months ended September 28, 2018 differs from the 2018 U.S. statutory rate of 21% mainly due to the effective settlement of uncertain tax positions, an enacted tax rate change in a foreign jurisdiction, valuation allowance reversals and the expected realization of certain U.S. tax credits, offset in part by losses in certain jurisdictions where a tax benefit is not expected to be recognized in 2018 . The Provision for income taxes for the three and nine months ended September 28, 2018 includes $4.4 million and $29.8 million of net discrete tax benefits, respectively.

Equity

Equity	9 Months Ended
Equity	Sep. 27, 2019
Equity [Abstract]
Shareholders' Equity and Share-based Payments [Text Block]	Equity Share Repurchase Program On February 12, 2018 , the Company’s Board of Directors authorized the repurchase of up to $100 million of the Company’s Common stock from time-to-time on the open market or in privately negotiated transactions. The Board of Directors increased the repurchase authorization by an additional $100 million on June 6, 2018 . On July 19, 2018 , the Board of Directors increased the repurchase authorization by another $100 million . The timing, amount and method of shares repurchased is determined by management based on its evaluation of market conditions and other factors. There were no repurchases made during the nine months ended September 27, 2019 . As of September 27, 2019 , the remaining stock repurchase authorization provided by the Company’s Board of Directors was $100.0 million . Accumulated Other Comprehensive Loss The following tables present the changes in the balances of each component of Accumulated other comprehensive loss including reclassifications out of Accumulated other comprehensive loss for the nine months ended September 27, 2019 and September 28, 2018 . All amounts are net of tax and noncontrolling interest, if any. Accumulated Other Comprehensive Loss Components Net Unrecognized Pension and Other Post-Retirement Benefit Cost Foreign Currency Translation Adjustment Unrealized Gain on Hedging Activities Total (In thousands) Balance at January 1, 2019 $ (80,794 ) $ (752,989 ) $ 38,238 $ (795,545 ) Other comprehensive income (loss) before reclassifications: Foreign currency translation adjustment 859 (120,722 ) (304 ) (120,167 ) Loss on long-term intra-entity foreign currency transactions — (4,197 ) — (4,197 ) Gain on net investment hedges — — 14,258 14,258 Unrealized gain on cash flow hedges — — 167 167 Other comprehensive income (loss) before reclassifications 859 (124,919 ) 14,121 (109,939 ) Amounts reclassified from Accumulated other comprehensive loss (1) (22,704 ) — — (22,704 ) Noncontrolling interest share repurchase — (20,962 ) — (20,962 ) Net Other comprehensive (loss) income (21,845 ) (145,881 ) 14,121 (153,605 ) Balance at September 27, 2019 $ (102,639 ) $ (898,870 ) $ 52,359 $ (949,150 ) Accumulated Other Comprehensive Loss Components Net Unrecognized Pension and Other Post-Retirement Benefit Cost Foreign Currency Translation Adjustment Unrealized Gain on Hedging Activities Total (In thousands) Balance at January 1, 2018 $ (84,338 ) $ (525,324 ) $ 30,138 $ (579,524 ) Other comprehensive income (loss) before reclassifications: Foreign currency translation adjustment 835 (173,041 ) (466 ) (172,672 ) Gain on long-term intra-entity foreign currency transactions — 6,777 — 6,777 Gain on net investment hedges — — 9,210 9,210 Unrealized loss on cash flow hedges — — (2,191 ) (2,191 ) Other comprehensive income (loss) before reclassifications 835 (166,264 ) 6,553 (158,876 ) Amounts reclassified from Accumulated other comprehensive loss (1) 2,506 — — 2,506 Net Other comprehensive income (loss) 3,341 (166,264 ) 6,553 (156,370 ) Balance at September 28, 2018 $ (80,997 ) $ (691,588 ) $ 36,691 $ (735,894 ) (1) Included in the computation of net periodic benefit cost. See Note 13, “Net Periodic Benefit Cost - Defined Benefit Plans” for additional details. Tangible equity unit (“TEU”) offering On January 11, 2019, the Company issued $460 million in tangible equity units. The Company offered 4 million of its 5.75% tangible equity units at the stated amount of $100 per unit. An option to purchase up to an additional 600,000 tangible equity units at the stated amount of $100 per unit was exercised in full at settlement. Total cash of $447.7 million was received upon closing. The proceeds from the issuance of the TEUs were allocated initially to equity and debt based on the relative fair value of the respective components of each TEU as follows: TEU prepaid stock purchase contracts TEU amortizing notes Total (In millions, except per unit amounts) Fair value per unit $ 84.39 $ 15.61 $ 100.00 Gross proceeds $ 388.2 $ 71.8 $ 460.0 Less: Issuance costs 10.4 1.9 12.3 Net proceeds $ 377.8 $ 69.9 $ 447.7 The $377.8 million fair value of the prepaid stock purchase contracts was recorded in Additional paid-in capital in the Condensed Consolidated Balance Sheets. The fair value of the $69.9 million of TEU amortizing notes due January 2022 has both a short-term and a long-term component. Upon the issuance of the TEUs, $47.3 million was initially recorded in Long-term debt, less current portion, and $22.6 million was initially recorded in Current portion of long-term debt in the Condensed Consolidated Balance Sheets. The Company deferred certain debt issuance costs associated with the debt component of the TEUs. These amounts offset the debt liability balance in the Condensed Consolidated Balance Sheets and are being amortized over its term. TEU prepaid stock purchase contracts Unless previously settled at the holder’s option, for each purchase contract the Company will deliver to holders on January 15, 2022 (subject to postponement in certain limited circumstances, the “mandatory settlement date”) a number of shares of common stock. The number of shares of common stock issuable upon settlement of each purchase contract (the “settlement rate”) will be determined using the arithmetic average of the volume average weighted price for the 20 consecutive trading days beginning on, and including, the 21st scheduled trading day immediately preceding January 15, 2022 (“the Applicable Market Value”) with reference to the following settlement rates: • if the Applicable Market Value of the common stock is greater than the threshold appreciation price of $25.00 , then the holder will receive 4.0000 shares of common stock for each purchase contract (the “minimum settlement rate”); • if the Applicable Market Value of the common stock is greater than or equal to the reference price of $20.81 , but less than or equal to the threshold appreciation price of $25.00 , then the holder will receive a number of shares of common stock for each purchase contract having a value, based on the Applicable Market Value, equal to $100 ; and • if the Applicable Market Value of the common stock is less than the reference price of $20.81 , then the holder will receive 4.8054 shares of common stock for each purchase contract (the “maximum settlement rate”). TEU amortizing notes Each TEU amortizing note has an initial principal amount of $15.6099 , bears interest at a rate of 6.50% per annum and has a final installment payment date of January 15, 2022. On each January 15, April 15, July 15 and October 15, commencing on April 15, 2019, the Company pays equal quarterly cash installments of $1.4375 per TEU amortizing note (except for the April 15, 2019 installment payment, which was $1.5014 per TEU amortizing note), which will constitute a payment of interest and a partial repayment of principal, and which cash payment in the aggregate per year will be equivalent to 5.75% per year with respect to the $100 stated amount per unit. The Company has paid $13.5 million representing a partial payment of principal and interest on the TEU amortizing notes in 2019. The TEU amortizing notes are the direct, unsecured and unsubordinated obligations of the Company and rank equally with all of the existing and future other unsecured and unsubordinated indebtedness of the Company. Earnings per share Unless the 4.6 million stock purchase contracts are redeemed by the Company or settled earlier at the unit holder’s option, they are mandatorily convertible into shares of Colfax common stock at not less than 4.0 shares per purchase contract or more than 4.8054 shares per purchase contract on January 15, 2022. This corresponds to not less than 18.4 million shares and not more than 22.1 million shares at the maximum. The 18.4 million minimum shares are included in the calculation of weighted-average shares of Common stock outstanding - basic. The difference between the minimum and maximum shares represents potentially dilutive securities. The Company includes them in its calculation of weighted-average shares of Common stock outstanding - diluted on a pro rata basis to the extent the average Applicable Market Value is higher than the reference price but is less than the conversion price. Repurchase of noncontrolling interest shares During the first quarter of 2019, a South Africa consolidated subsidiary of the Company repurchased substantially all of the noncontrolling interest shares from existing shareholders under a general offer. During the second quarter of 2019, the Company completed the repurchase of the remaining noncontrolling interest shares. As a part of the Air and Gas Handling business, this subsidiary is reported within held for sale and its results of operations are included in discontinued operations for all periods presented.

Inventories, Net (Text Block)

Inventories, Net (Text Block)	9 Months Ended
Inventories, Net (Text Block)	Sep. 27, 2019
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	Inventories, Net Inventories, net consisted of the following: September 27, 2019 December 31, 2018 (In thousands) Raw materials $ 121,930 $ 120,383 Work in process 41,777 27,834 Finished goods 482,631 245,571 646,338 393,788 Less: allowance for excess, slow-moving and obsolete inventory (61,987 ) (34,133 ) Inventories, net $ 584,351 $ 359,655

Leases

Leases	9 Months Ended
Leases	Sep. 27, 2019
Leases [Abstract]
Leases	Leases The Company leases certain office spaces, warehouses, facilities, vehicles, and equipment. Leases with an initial term of twelve months or less are not recorded on the balance sheet. Most leases include renewal options, which can extend the lease term into the future. The Company determines the lease term by assuming options that are reasonably certain of being renewed will be exercised. Certain of the Company’s leases include rental payments adjusted for inflation. The right-of-use lease asset and lease liability are recorded on the Condensed Consolidated Balance Sheet, with the current lease liability being included in Accrued liabilities. Operating lease expense approximated cash paid for leases during the nine months ended September 27, 2019 . Quantitative information regarding the Company’s leases is as follows: Nine Months Ended September 27, 2019 (In thousands) Operating lease expense $ 28,340 As of September 27, 2019 Future lease payments by year: (In thousands) 2019 $ 10,468 2020 38,244 2021 30,100 2022 22,416 2023 18,584 Thereafter 65,238 Total 185,050 Less: present value discount (25,051 ) Present value of lease liabilities $ 159,999 Weighted-average remaining lease term (in years): Operating leases 8.1 Weighted-average discount rate: Operating leases 3.5 %

Debt (Text Block)

Debt (Text Block)	9 Months Ended
Debt (Text Block)	Sep. 27, 2019
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	Debt Long-term debt consisted of the following: September 27, 2019 December 31, 2018 (In thousands) Term loans $ 1,675,826 $ 485,959 Euro senior notes 379,030 395,420 TEU amortizing notes 59,452 — 2024 and 2026 notes 988,715 — Revolving credit facilities and other 928,996 316,049 Total debt 4,032,019 1,197,428 Less: current portion (29,654 ) (5,020 ) Long-term debt $ 4,002,365 $ 1,192,408 Term Loan Facilities and Revolving Credit Facility On December 17, 2018, the Company entered into a credit agreement (the “Credit Facility”) by and among the Company, as the borrower, certain U.S. subsidiaries of the Company identified therein, as guarantors, each of the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, Credit Suisse Loan Funding LLC, as syndication agent, and the co-documentation agents named therein. The Credit Facility consists of a revolving credit facility which totals $1.3 billion in commitments (the “Revolver”) and a Term A-1 loan in an aggregate amount of $1.2 billion (the “Five Year Term Loan”), each of which matures in five years, and a Term A-2 loan in an aggregate amount of $500 million , which matures in two years (the “Two Year Term Loan” and, together with the Five Year Term Loan, the “Term Loan Facilities”). The Revolver contains a $50 million swing line loan sub-facility. The initial credit extensions under the Credit Facility were only made available to the Company on the date of consummation of the DJO acquisition, which occurred on February 22, 2019. See Note 4, “Acquisition” for details. The Term Loan Facilities and the Revolver bear interest, at the Company’s election, at either the base rate (as defined in the Credit Facility) or the Eurocurrency rate (as defined in the Credit Facility), in each case, plus the applicable interest rate margin. The Term Loan Facilities and the Revolver initially bear interest either at the Eurocurrency rate plus 1.75% or at the base rate plus 0.75% , and in future quarters will bear interest either at the Eurocurrency rate or the base rate plus the applicable interest rate margin based upon either, whichever results in the lower applicable interest rate margin (subject to certain exceptions), the Company’s total leverage ratio and the Company’s corporate family credit rating as determined by Standard & Poor’s and Moody’s (ranging from 1.25% to 2.00% , in the case of the Eurocurrency margin, and 0.25% to 1.00% , in the case of the base rate margin). Each swing line loan denominated in dollars bears interest at the base rate plus the applicable interest rate margin and each swing line loan denominated in any other currency available under the Credit Facility bears interest at the Eurocurrency rate plus the applicable interest rate margin. Certain of the Company’s U.S. subsidiaries agreed to guarantee the Company’s obligations under the Credit Facility. The Credit Facility contains customary covenants limiting the ability of Colfax and its subsidiaries to, among other things, incur debt or liens, merge or consolidate with others, dispose of assets, make investments or pay dividends. In addition, the Credit Facility contains financial covenants requiring Colfax to maintain (subject to certain exceptions) (i) a maximum total leverage ratio, calculated as Consolidated Total Debt (as defined in the Credit Facility) divided by EBITDA (as defined in the Credit Facility) of, initially, 6.00 :1.00, with a step-down to 5.50 :1.00 at the end of the second and third fiscal quarters following the consummation of the DJO acquisition, 4.75 :1.00 at the end of the fourth and fifth fiscal quarters, 4.25 :1.00 at the end of the sixth fiscal quarter, 4.00 :1.00 at the end of the seventh fiscal quarter, and 3.50 :1.00 at the end of the eighth fiscal quarter, and (ii) a minimum interest coverage ratio of 3.00 :1:00. The Credit Facility also contains a “springing” collateral provision, which will require the obligations under the Credit Facility to be secured by substantially all personal property of Colfax and its U.S. subsidiaries, subject to customary exceptions, within an agreed period of time if Colfax’s total leverage ratio under the Credit Facility is greater than or equal to 3.75 :1.00 for two consecutive fiscal quarters following the fourth fiscal quarter ending after consummation of the DJO acquisition. The Credit Facility contains various events of default (including failure to comply with the covenants under the Credit Facility and related agreements) and upon an event of default the lenders may, subject to various customary cure rights, require the immediate payment of all amounts outstanding under the Term Loan Facilities and the Revolver. As of September 27, 2019 , the Company is in compliance with the covenants under the Credit Facility. The proceeds of the loans under the Credit Facility were used by the Company to repay in full its preexisting credit agreement (the “DB Credit Agreement”) by and among the Company, as the borrower, certain U.S. subsidiaries of the Company identified therein, as guarantors, each of the lenders party thereto and Deutsche Bank AG New York Branch, as administrative agent, swing line lender and global coordinator, as well as to pay a portion of the consideration paid by the Company in connection with the DJO acquisition and other related fees. In conjunction with the Credit Facility, the Company recorded a charge to Interest expense, net in the Condensed Consolidated Statement of Operations for the nine months ended September 27, 2019 of $0.8 million to write-off certain original issue discount and deferred financing fees associated with the DB Credit Agreement. In association with the Credit Facility, the Company recorded an aggregate $12.8 million in deferred financing fees, which is being accreted to Interest expense, net primarily using the effective interest method, over the life of the Credit Facility. As of September 27, 2019 , the weighted-average interest rate of borrowings under the Credit Facility was 4.22% , excluding accretion of original issue discount and deferred financing fees, and there was $415.0 million available on the Revolver. The Credit Facility also requires, under certain circumstances, any funds received as net proceeds from the sale of certain of the Company’s assets or subsidiaries be used to repay outstanding balances on the Term Loan Facilities, as well as outstanding balances under the Revolver. Accordingly, a corresponding amount of interest associated with the Term Loan Facilities and and Revolver has been included in Loss from discontinued operations, net of taxes on the Condensed Consolidated Statement of Operations. On September 25, 2019, the Company entered into Amendment No. 1 to the Credit Facility, which clarified the pre-payment steps required to be taken with the use of any such net proceeds. Subsequent to the end of the quarter on September 30, 2019, upon the completion of the sale of its Air and Gas Handling business, the Company used $1.65 billion of the proceeds to repay a portion of the Term Loan Facilities and the Revolver. Euro Senior Notes On April 19, 2017, the Company issued senior unsecured notes with an aggregate principal amount of €350 million (the “Euro Senior Notes”). The Euro Senior Notes are due in April 2025 and have an interest rate of 3.25% . The proceeds from the Euro Senior Notes offering were used to repay borrowings under the DB Credit Agreement and bilateral credit facilities totaling €283.5 million , as well as for general corporate purposes, and are guaranteed by certain of the Company’s domestic subsidiaries (the "Guarantees"). In conjunction with the issuance, the Company recorded $6.0 million of deferred financing fees. The Euro Senior Notes and the Guarantees have not been, and will not be, registered under the Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any other jurisdiction. TEU Amortizing Notes On January 11, 2019, the Company issued $460 million in tangible equity units. The Company offered 4 million of its 5.75% tangible equity units at the stated amount of $100 per unit. An option to purchase up to an additional 600,000 tangible equity units at the stated amount of $100 per unit was exercised in full at settlement. Total cash of $447.7 million was received upon closing, comprised of $377.8 million TEU prepaid stock purchase contracts and $69.9 million of TEU amortizing notes due January 2022. The proceeds were used to finance a portion of the purchase price for the DJO acquisition and for general corporate purposes. For more information, refer to Note 8, “Equity.” 2024 Notes and 2026 Notes On February 5, 2019, two tranches of senior notes with aggregate principal amounts of $600 million (the “2024 Notes”) and $400 million (the “2026 Notes”) were issued by CFX Escrow Corporation, an unaffiliated special purpose finance entity established to issue the notes and incorporated in the State of Delaware, to finance a portion of the DJO acquisition. The 2024 Notes are due on February 15, 2024 and have an interest rate of 6.0% . The 2026 Notes are due on February 15, 2026 and have an interest rate of 6.375% . Upon closing of the DJO acquisition, the Company assumed all of CFX Escrow Corporation’s obligations under the 2024 Notes and 2026 Notes. Each tranche of notes is guaranteed by certain of the Company’s domestic subsidiaries. Other Indebtedness In addition to the debt agreements discussed above, the Company is party to various bilateral credit facilities with a borrowing capacity of $267.4 million . As of September 27, 2019 , outstanding borrowings under these facilities were $35.0 million , and had a weighted average borrowing rate of 3.75% . Additionally, as discussed in Note 8, “Equity”, the Company repurchased repurchased substantially all of the noncontrolling interest shares of its South Africa consolidated subsidiary during the first quarter of 2019. During the second quarter of 2019, the Company completed the repurchase of the remaining noncontrolling interest shares. Based on local requirements, the Company was required to enter into a debt arrangement to enact the repurchases. The outstanding loan balance associated with this transaction was repaid in the the second quarter of 2019. As of September 27, 2019 , there is no outstanding balance on the Company’s Condensed Consolidated Balance Sheets related to this debt arrangement. The continuing operations of the Company is also party to letter of credit facilities with total capacity of $498.2 million . Total letters of credit of $57.8 million were outstanding as of September 27, 2019 . In total, the Company had deferred financing fees of $26.7 million included in its Condensed Consolidated Balance Sheet as of September 27, 2019 , which will be charged to Interest expense, net, primarily using the effective interest method, over the life of the applicable debt agreements.

Accrued Liabilities (Text Block

Accrued Liabilities (Text Block)	9 Months Ended
Accrued Liabilities (Text Block)	Sep. 27, 2019
Accrued Liabilities [Abstract]
Accrued Liabilities Disclosure [Text Block]	Accrued Liabilities Accrued liabilities in the Condensed Consolidated Balance Sheets consisted of the following: September 27, 2019 December 31, 2018 (In thousands) Accrued compensation and related benefits $ 98,623 $ 72,216 Accrued taxes 49,325 55,554 Accrued asbestos-related liability 63,339 56,045 Warranty liability - current portion 15,899 12,312 Accrued restructuring liability - current portion 7,857 5,475 Accrued third-party commissions 27,607 15,765 Lease liability - current portion 36,761 — Accrued interest 14,551 2,956 Other 117,371 53,694 Accrued liabilities $ 431,333 $ 274,017 Warranty Liability The activity in the Company’s warranty liability consisted of the following: Nine Months Ended September 27, 2019 September 28, 2018 (In thousands) Warranty liability, beginning of period $ 12,312 $ 10,949 Accrued warranty expense 5,456 5,456 Changes in estimates related to pre-existing warranties 1,256 1,171 Cost of warranty service work performed (7,783 ) (5,900 ) Acquisition-related liability 5,356 — Foreign exchange translation effect (427 ) (478 ) Warranty liability, end of period $ 16,170 $ 11,198 Accrued Restructuring Liability The Company’s restructuring programs include a series of actions to reduce the structural costs of the Company. A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Condensed Consolidated Balance Sheets is as follows: Nine Months Ended September 27, 2019 Balance at Beginning of Period Acquisitions Provisions Payments Foreign Currency Translation Balance at End of Period (3) (In thousands) Restructuring and other related charges: Fabrication Technology: Termination benefits (1) $ 5,494 $ — $ 6,414 $ (8,051 ) $ (454 ) $ 3,403 Facility closure costs (2) 662 — 5,849 (6,475 ) 27 63 Fabrication Technology subtotal 6,156 — 12,263 (14,526 ) (427 ) 3,466 Non-cash charges (2) 702 12,965 Medical Technology: Termination benefits (1) — 6,096 4,734 (5,723 ) — 5,107 Facility closure costs (2) — — 33,026 (21,640 ) — 11,386 Medical Technology subtotal — 6,096 37,760 (27,363 ) — 16,493 Total $ 6,156 $ 6,096 $ 50,023 $ (41,889 ) $ (427 ) $ 19,959 Non-cash charges (2) 702 $ 50,725 (1) Includes severance and other termination benefits, including outplacement services. (2) Includes the cost of relocating associates, relocating equipment and lease termination expense in connection with the closure of facilities. During the nine months ended September 27, 2019 , the Company recorded an $0.7 million non-cash impairment charge for facilities in the Fabrication Technology segment as part of Corporate approved restructuring activities. Restructuring charges in the Medical Technology segment during the nine months ended September 27, 2019 includes costs related to product and distribution channel transformations, facilities optimization, and integration charges. Restructuring charges in the Medical Technology segment also includes $3.5 million classified as Cost of sales on the Company’s Condensed Consolidated Statements of Operations for the nine months ended September 27, 2019 . (3) As of September 27, 2019 , $7.9 million and $0.7 million of the Company’s restructuring liability was included in Accrued liabilities and Other liabilities, respectively, and $11.4 million was included in Accounts payable.

Net Periodic Benefit Cost-Defin

Net Periodic Benefit Cost-Defined Benefit Plans (Text Block)	9 Months Ended
	Sep. 27, 2019
Retirement Benefits [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	Net Periodic Benefit Cost - Defined Benefit Plans The following table sets forth the components of total net periodic benefit cost of the Company’s defined benefit pension plans and other post-retirement employee benefit plans: Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (In thousands) Pension Benefits - U.S. Plans: Service cost $ 33 $ 20 $ 101 101 Interest cost 1,798 1,155 5,393 4,776 Expected return on plan assets (2,660 ) (2,969 ) (7,980 ) (8,247 ) Amortization 776 606 2,327 2,434 Net periodic benefit income $ (53 ) $ (1,188 ) $ (159 ) $ (936 ) Pension Benefits - Non-U.S. Plans: Service cost $ 427 $ 407 $ 1,105 $ 1,154 Interest cost 2,176 2,928 6,705 9,088 Expected return on plan assets (2,181 ) (3,263 ) (6,739 ) (10,139 ) Settlement loss 33,616 — 33,616 — Amortization 102 259 287 801 Net periodic benefit cost $ 34,140 $ 331 $ 34,974 $ 904 Other Post-Retirement Benefits: Service cost $ 1 $ 6 $ 4 $ 19 Interest cost 122 124 366 370 Amortization (37 ) (22 ) (112 ) (66 ) Net periodic benefit cost $ 86 $ 108 $ 258 $ 323 During the three months ended September 27, 2019 , the Company settled a non-U.S. pension plan in its Fabrication Technology segment through a third-party buyout arrangement. As a result of the settlement, the Company is no longer responsible for any liabilities under the plan and recognized a loss of $33.6 million , which is reflected in Pension settlement loss in the Consolidated Statements of Operations.

Financial Instruments and Fair

Financial Instruments and Fair Value Measurements (Text Block)	9 Months Ended
	Sep. 27, 2019
Financial Instruments and Fair Value Measurements [Abstract]
Fair Value Assets and Liabilities Measured On Recurring and Nonrecurring Basis [Text Block]	Financial Instruments and Fair Value Measurements The carrying values of financial instruments, including Trade receivables and Accounts payable, approximate their fair values due to their short-term maturities. The $4.0 billion and $1.2 billion estimated fair value of the Company’s debt as of September 27, 2019 and December 31, 2018 , respectively, was based on current interest rates for similar types of borrowings and is in Level Two of the fair value hierarchy. The estimated fair values may not represent actual values of the financial instruments that could be realized as of the balance sheet date or that will be realized in the future. A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows: September 27, 2019 Level Level Level Total (In thousands) Assets: Cash equivalents $ 17,740 $ — $ — $ 17,740 Foreign currency contracts related to sales - not designated as hedges — 378 — 378 Foreign currency contracts related to purchases - not designated as hedges — 527 — 527 Deferred compensation plans — 8,297 — 8,297 $ 17,740 $ 9,202 $ — $ 26,942 Liabilities: Foreign currency contracts related to sales - not designated as hedges $ — $ 23 $ — $ 23 Foreign currency contracts related to purchases - not designated as hedges — 809 — 809 Deferred compensation plans — 8,297 — 8,297 $ — $ 9,129 $ — $ 9,129 December 31, 2018 Level Level Level Total (In thousands) Assets: Cash equivalents $ 5,388 $ — $ — $ 5,388 Foreign currency contracts related to sales - not designated as hedges — 326 — 326 Foreign currency contracts related to purchases - not designated as hedges — 325 — 325 Deferred compensation plans — 7,154 — 7,154 $ 5,388 $ 7,805 $ — $ 13,193 Liabilities: Foreign currency contracts related to sales - not designated as hedges $ — $ 133 $ — $ 133 Foreign currency contracts related to purchases - not designated as hedges — 557 — 557 Deferred compensation plans — 7,154 — 7,154 $ — $ 7,844 $ — $ 7,844 There were no transfers in or out of Level One, Two or Three during the nine months ended September 27, 2019 . Foreign Currency Contracts As of September 27, 2019 and December 31, 2018 , the Company had foreign currency contracts with the following notional values: September 27, 2019 December 31, 2018 (In thousands) Foreign currency contracts sold - not designated as hedges $ 24,868 $ 43,510 Foreign currency contracts purchased - not designated as hedges 90,992 75,102 Total foreign currency derivatives $ 115,860 $ 118,612 The Company recognized the following in its Condensed Consolidated Financial Statements related to its derivative instruments: Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (In thousands) Contracts Designated as Hedges: Unrealized gain on net investment hedges (1) $ 12,807 $ 671 $ 14,258 $ 9,210 Contracts Not Designated in a Hedge Relationship: Foreign Currency Contracts - related to customer sales contracts: Unrealized gain (loss) 423 (476 ) 215 1,173 Realized loss (165 ) (596 ) (1,232 ) (49 ) Foreign Currency Contracts - related to supplier purchases contracts: Unrealized (loss) gain (732 ) 174 (81 ) (1,631 ) Realized gain 1 397 455 73 (1)

Commitments and Contingencies (

Commitments and Contingencies (Text Block)	9 Months Ended
Commitments and Contingencies (Text Block)	Sep. 27, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Commitments and Contingencies For further description of the Company’s litigation and contingencies, reference is made to Note 17, “Commitments and Contingencies” in the Notes to the Consolidated Financial Statements in the Company’s 2018 Form 10-K. Since the Company did not retain an interest in the ongoing operations of the divested Fluid Handling business, the retained asbestos-related activity has been classified in its Condensed Consolidated Statements of Operations as a component of Loss from discontinued operations, net of taxes. Asbestos Contingencies Claims activity since December 31 related to asbestos claims is as follows: Nine Months Ended September 27, 2019 September 28, 2018 (Number of claims) Claims unresolved, beginning of period 16,417 17,737 Claims filed (1) 3,360 2,982 Claims resolved (2) (3,604 ) (4,450 ) Claims unresolved, end of period 16,173 16,269 (1) Claims filed include all asbestos claims for which notification has been received or a file has been opened. (2) Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants. The Company’s Condensed Consolidated Balance Sheets included the following amounts related to asbestos-related litigation: September 27, 2019 December 31, 2018 (In thousands) Current asbestos insurance receivable (1) $ 24,826 $ — Long-term asbestos insurance asset (2) 271,095 278,662 Long-term asbestos insurance receivable (2) 43,802 62,523 Accrued asbestos liability (3) 63,339 56,045 Long-term asbestos liability (4) 268,675 288,962 (1) Included in Other current assets in the Condensed Consolidated Balance Sheets. (2) Included in Other assets in the Condensed Consolidated Balance Sheets. (3) Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay, and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Condensed Consolidated Balance Sheets. (4) Included in Other liabilities in the Condensed Consolidated Balance Sheets. Management’s analyses are based on currently known facts and assumptions. Projecting future events, such as new claims to be filed each year, the average cost of resolving each claim, coverage issues among layers of insurers, the method in which losses will be allocated to the various insurance policies, interpretation of the effect on coverage of various policy terms and limits and their interrelationships, the continuing solvency of various insurance companies, the amount of remaining insurance available, as well as the numerous uncertainties inherent in asbestos litigation could cause the actual liabilities and insurance recoveries to be higher or lower than those projected or recorded which could materially affect the Company’s financial condition, results of operations or cash flow. Over the next year, the Company expects to be reimbursed for certain asbestos-related costs that were mainly incurred prior to certain court rulings. Other Litigation Matters

Segment Information (Text Block

Segment Information (Text Block)	9 Months Ended
Segment Information (Text Block)	Sep. 27, 2019
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	Segment Information Prior to entering into the Purchase Agreement, the Company conducted its operations through three operating segments: Air and Gas Handling, Fabrication Technology, and Medical Technology. Subsequent to the Purchase Agreement date, the Company conducts its continuing operations through two operating segments: Fabrication Technology and Medical Technology, which also represent the Company’s reportable segments. ▪ Fabrication Technology - a global supplier of welding equipment, cutting equipment, automated welding and cutting systems, and consumables. • Medical Technology - a leading provider of orthopedic solutions, providing orthopedic devices, software and services spanning the full continuum of patient care, from injury prevention to rehabilitation. Certain amounts not allocated to the two reportable segments and intersegment eliminations are reported under the heading “Corporate and other.” The Company’s management evaluates the operating results of each of its reportable segments based upon Net sales and segment operating income, which represents Operating income before Restructuring and other related charges. The Company’s segment results were as follows: Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (In thousands) Net sales: Fabrication Technology $ 539,228 $ 524,022 $ 1,692,347 $ 1,618,152 Medical Technology 307,291 — 746,738 — $ 846,519 $ 524,022 $ 2,439,085 $ 1,618,152 Segment operating income (1) : Fabrication Technology $ 72,999 $ 55,634 $ 224,574 $ 190,864 Medical Technology 22,456 — 37,743 — Corporate and other (14,285 ) (13,919 ) (99,864 ) (46,453 ) $ 81,170 $ 41,715 $ 162,453 $ 144,411 (1) Following is a reconciliation of Income (loss) from continuing operations before income taxes to segment operating income: Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (In thousands) Income (loss) from continuing operations before income taxes $ 2,417 $ 23,445 $ (8,708 ) $ 81,185 Loss on short-term investments — — — 10,128 Pension settlement loss 33,616 — 33,616 — Interest expense, net 31,828 11,611 86,820 33,455 Restructuring and other related charges (1) 13,309 6,659 50,725 19,643 Segment operating income $ 81,170 $ 41,715 $ 162,453 $ 144,411 (1) Restructuring and other related charges includes $3.5 million of expense classified as Cost of sales on the Company’s Condensed Consolidated Statements of Operations for the three and nine months ended September 27, 2019 .

Subsequent Events (Notes)

Subsequent Events (Notes)	9 Months Ended
Subsequent Events (Notes)	Sep. 27, 2019
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events On September 30, 2019, the Company completed the sale of its Air and Gas Handling business to the Purchaser for $1.8 billion , including $1.67 billion of cash paid at closing and the assumption of certain liabilities and minority interests. The purchase consideration is subject to certain adjustments pursuant to the Purchase Agreement which have not been finalized. The Company does not expect a material impact from adjustments associated with finalizing the purchase consideration. On September 30, 2019, the Company used $1.65 billion of the proceeds, as required by the Credit Facility, to repay a portion of the Term Loan Facilities and the Revolver.

Discontinued Operations (Tables

Discontinued Operations (Tables)	9 Months Ended
Discontinued Operations (Tables)	Sep. 27, 2019
Discontinued Operations [Abstract]
Disposal Groups, Including Discontinued Operations [Table Text Block]	The key components of Income (loss) from discontinued operations, net of taxes related to the Air and Gas Handling business for the three and nine months ended September 27, 2019 and September 28, 2018 were as follows: Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (In thousands) Net sales $ 338,885 $ 351,351 $ 998,793 $ 1,063,434 Cost of sales 230,692 251,695 689,004 782,232 Selling, general and administrative expense 65,117 65,275 194,562 196,766 Restructuring and other related charges 4,987 9,257 13,354 21,148 Held for sale impairment loss — — 481,000 — Divestiture-related expense (1) 4,481 — 11,692 — Operating income (loss) 33,608 25,124 (390,819 ) 63,288 Interest expense (income) (2) 12,779 (1,726 ) 38,899 (4,302 ) Pension settlement loss — — 43,774 — Income (loss) from discontinued operations before income taxes 20,829 26,850 (473,492 ) 67,590 Income tax expense 9,809 5,610 5,387 15,566 Income (loss) from discontinued operations, net of taxes $ 11,020 $ 21,240 $ (478,879 ) $ 52,024 (1) Primarily related to professional and consulting fees associated with the divestiture including seller due diligence and preparation of regulatory filings, as well as other disposition-related activities. (2) The Company reclassified the portion of its interest expense associated with its Term Loan Facilities that is associated with the mandatory repayment using net proceeds from the sale of the business. Total income attributable to noncontrolling interest related to the Air and Gas Handling business, net of taxes was $1.5 million , $3.5 million , $5.9 million , and $10.0 million for the three months ended September 27, 2019 and September 28, 2018 and the nine months ended September 27, 2019 and September 28, 2018 , respectively. The following table summarizes the major classes of assets and liabilities held for sale that were included in the Company’s consolidated balance sheets as of September 27, 2019 and December 31, 2018 : September 27, 2019 December 31, 2018 (In thousands) ASSETS HELD FOR SALE Cash and cash equivalents $ 39,695 $ 167,866 Trade receivables, less allowance for doubtful accounts of $8,783 and $8,308 520,379 602,830 Inventories, net 155,877 136,880 Other current assets 61,079 89,668 Property, plant, and equipment, net 184,035 176,189 Goodwill 599,544 1,078,785 Intangible assets, net 365,728 384,613 Other assets 110,508 101,118 Valuation allowance on assets held for sale (23,500 ) — Total assets held for sale 2,013,345 2,737,949 Less: current portion 2,013,345 997,244 Total assets held for sale, less current portion $ — $ 1,740,705 LIABILITIES HELD FOR SALE Current portion of long-term debt $ 1,137 $ 1,314 Accounts payable 256,955 349,434 Customer advances and billings in excess of costs incurred 158,324 130,480 Accrued liabilities 140,354 131,020 Other liabilities 94,948 95,395 Total liabilities held for sale 651,718 707,643 Less: current portion 651,718 612,248 Total liabilities held for sale, less current portion $ — $ 95,395

Acquisitions Acquisitions (Tabl

Acquisitions Acquisitions (Tables)	9 Months Ended
Acquisitions Acquisitions (Tables)	Sep. 27, 2019
Business Combinations [Abstract]
Business Acquisition, Pro Forma Information [Table Text Block]	These amounts are presented in accordance with GAAP, consistent with the Company’s accounting policies. Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (Unaudited, in thousands) Net sales $ 846,519 $ 818,073 $ 2,608,251 $ 2,509,669 Net income (loss) from continuing operations attributable to Colfax Corporation 7,676 (3,025 ) 72,857 39,582
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	The following table summarizes the Company’s current estimate of the aggregate fair value of the assets acquired and liabilities assumed at the date of acquisition. These amounts, including inventories, deferred taxes, intangible assets, useful lives of the intangible assets, and property, plant and equipment, are determined based upon certain valuations and studies that have yet to be finalized. Accordingly, the assets acquired and liabilities assumed, as detailed below, are subject to adjustment once the detailed analyses are completed, which could be material. Substantially all of the Goodwill recognized is not expected to be deductible for income tax purposes. February 22, 2019 (In thousands) Trade receivables $ 160,234 Inventories 208,619 Property, plant and equipment 170,601 Goodwill 1,301,451 Intangible assets 1,737,000 Accounts payable (108,540 ) Other assets and liabilities, net (337,402 ) Total 3,131,963 Less: net assets attributable to noncontrolling interest (1,861 ) Consideration, net of cash acquired $ 3,130,102
Schedule of Indefinite-lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]	The following table summarizes preliminary Intangible assets acquired, excluding Goodwill, as of February 22, 2019: Intangible Asset Weighted-Average Amortization Period (In thousands) (Years) Trademarks $ 479,000 16 Customer relationships 954,000 14 Acquired technology 304,000 12 Intangible assets $ 1,737,000

Revenue (Tables)

Revenue (Tables)	9 Months Ended
Revenue (Tables)	Sep. 27, 2019
Revenue [Abstract]
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]	The Company’s Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment. Substantially all revenue from the Fabrication Technology business is recognized at a point in time. The Company disaggregates its Fabrication Technology revenue into the following product groups: Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (In thousands) Equipment $ 162,531 $ 143,130 $ 525,148 $ 441,994 Consumables 376,697 380,892 1,167,199 1,176,158 Total $ 539,228 $ 524,022 $ 1,692,347 $ 1,618,152 Contracts with customers in the consumables product grouping generally have a shorter fulfillment period than equipment contracts. The Company’s Medical Technology segment provides products and services spanning the full continuum of patient care, from injury prevention to rehabilitation. The Company’s Medical Technology sales are primarily derived from three sales channels including dealers and distributors, insurance, and direct to consumers and hospitals. Substantially all its revenue from the Medical Technology business is recognized at a point in time. The Company disaggregates its Medical Technology revenue into the following product groups: Three Months Ended September 27, 2019 Nine Months Ended September 27, 2019 (In thousands) Prevention & Rehabilitation $ 221,314 $ 533,986 Reconstructive 85,977 212,752 Total $ 307,291 $ 746,738

Net Income Per Share (Tables)

Net Income Per Share (Tables)	9 Months Ended
Net Income Per Share (Tables)	Sep. 27, 2019
Earnings Per Share [Abstract]
Schedule of Earnings Per Share - Basic and Diluted [Table Text Block]	Net income (loss) per share from continuing operations was computed as follows: Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (In thousands, except share data) Computation of Net income (loss) per share from continuing operations: Net income (loss) from continuing operations attributable to Colfax Corporation (1) $ 2,901 $ 16,231 $ (18,636 ) $ 83,520 Weighted-average shares of Common stock outstanding - basic 136,121,017 117,709,725 135,440,566 121,283,339 Net income (loss) per share from continuing operations - basic $ 0.02 $ 0.14 $ (0.14 ) $ 0.69 Computation of Net income (loss) per share from continuing operations - diluted: Net income (loss) from continuing operations attributable to Colfax Corporation (1) $ 2,901 $ 16,231 $ (18,636 ) $ 83,520 Weighted-average shares of Common stock outstanding - basic 136,121,017 117,709,725 135,440,566 121,283,339 Net effect of potentially dilutive securities - stock options and restricted stock units 929,143 747,211 — 518,179 Weighted-average shares of Common stock outstanding - diluted 137,050,160 118,456,936 135,440,566 121,801,518 Net income (loss) per share from continuing operations - diluted $ 0.02 $ 0.14 $ (0.14 ) $ 0.69 (1) Net income (loss) from continuing operations attributable to Colfax Corporation for the respective periods is calculated using Net income (loss) from continuing operations less the continuing operations component of the income attributable to noncontrolling interest, net of taxes of $0.9 million and $3.1 million for the three and nine months ended September 27, 2019 and $0.4 million and $1.7 million for the three and nine months ended September 28, 2018 , respectively.

Equity (Tables)

Equity (Tables)	9 Months Ended
Equity (Tables)	Sep. 27, 2019
Equity [Abstract]
Tangible Equity Units	The proceeds from the issuance of the TEUs were allocated initially to equity and debt based on the relative fair value of the respective components of each TEU as follows: TEU prepaid stock purchase contracts TEU amortizing notes Total (In millions, except per unit amounts) Fair value per unit $ 84.39 $ 15.61 $ 100.00 Gross proceeds $ 388.2 $ 71.8 $ 460.0 Less: Issuance costs 10.4 1.9 12.3 Net proceeds $ 377.8 $ 69.9 $ 447.7
Accumulated Other Comprehensive Loss	The following tables present the changes in the balances of each component of Accumulated other comprehensive loss including reclassifications out of Accumulated other comprehensive loss for the nine months ended September 27, 2019 and September 28, 2018 . All amounts are net of tax and noncontrolling interest, if any. Accumulated Other Comprehensive Loss Components Net Unrecognized Pension and Other Post-Retirement Benefit Cost Foreign Currency Translation Adjustment Unrealized Gain on Hedging Activities Total (In thousands) Balance at January 1, 2019 $ (80,794 ) $ (752,989 ) $ 38,238 $ (795,545 ) Other comprehensive income (loss) before reclassifications: Foreign currency translation adjustment 859 (120,722 ) (304 ) (120,167 ) Loss on long-term intra-entity foreign currency transactions — (4,197 ) — (4,197 ) Gain on net investment hedges — — 14,258 14,258 Unrealized gain on cash flow hedges — — 167 167 Other comprehensive income (loss) before reclassifications 859 (124,919 ) 14,121 (109,939 ) Amounts reclassified from Accumulated other comprehensive loss (1) (22,704 ) — — (22,704 ) Noncontrolling interest share repurchase — (20,962 ) — (20,962 ) Net Other comprehensive (loss) income (21,845 ) (145,881 ) 14,121 (153,605 ) Balance at September 27, 2019 $ (102,639 ) $ (898,870 ) $ 52,359 $ (949,150 ) Accumulated Other Comprehensive Loss Components Net Unrecognized Pension and Other Post-Retirement Benefit Cost Foreign Currency Translation Adjustment Unrealized Gain on Hedging Activities Total (In thousands) Balance at January 1, 2018 $ (84,338 ) $ (525,324 ) $ 30,138 $ (579,524 ) Other comprehensive income (loss) before reclassifications: Foreign currency translation adjustment 835 (173,041 ) (466 ) (172,672 ) Gain on long-term intra-entity foreign currency transactions — 6,777 — 6,777 Gain on net investment hedges — — 9,210 9,210 Unrealized loss on cash flow hedges — — (2,191 ) (2,191 ) Other comprehensive income (loss) before reclassifications 835 (166,264 ) 6,553 (158,876 ) Amounts reclassified from Accumulated other comprehensive loss (1) 2,506 — — 2,506 Net Other comprehensive income (loss) 3,341 (166,264 ) 6,553 (156,370 ) Balance at September 28, 2018 $ (80,997 ) $ (691,588 ) $ 36,691 $ (735,894 ) (1) Included in the computation of net periodic benefit cost. See Note 13, “Net Periodic Benefit Cost - Defined Benefit Plans” for additional details.

Inventories, Net (Tables)

Inventories, Net (Tables)	9 Months Ended
Inventories, Net (Tables)	Sep. 27, 2019
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventories, net consisted of the following: September 27, 2019 December 31, 2018 (In thousands) Raw materials $ 121,930 $ 120,383 Work in process 41,777 27,834 Finished goods 482,631 245,571 646,338 393,788 Less: allowance for excess, slow-moving and obsolete inventory (61,987 ) (34,133 ) Inventories, net $ 584,351 $ 359,655

Leases (Tables)

Leases (Tables)	9 Months Ended
Leases (Tables)	Sep. 27, 2019
Leases [Abstract]
Lessee, Operating Lease, Liability, Maturity	Quantitative information regarding the Company’s leases is as follows: Nine Months Ended September 27, 2019 (In thousands) Operating lease expense $ 28,340 As of September 27, 2019 Future lease payments by year: (In thousands) 2019 $ 10,468 2020 38,244 2021 30,100 2022 22,416 2023 18,584 Thereafter 65,238 Total 185,050 Less: present value discount (25,051 ) Present value of lease liabilities $ 159,999 Weighted-average remaining lease term (in years): Operating leases 8.1 Weighted-average discount rate: Operating leases 3.5 %

Debt (Tables)

Debt (Tables)	9 Months Ended
Debt (Tables)	Sep. 27, 2019
Debt Disclosure [Abstract]
Schedule of Debt [Table Text Block]	Long-term debt consisted of the following: September 27, 2019 December 31, 2018 (In thousands) Term loans $ 1,675,826 $ 485,959 Euro senior notes 379,030 395,420 TEU amortizing notes 59,452 — 2024 and 2026 notes 988,715 — Revolving credit facilities and other 928,996 316,049 Total debt 4,032,019 1,197,428 Less: current portion (29,654 ) (5,020 ) Long-term debt $ 4,002,365 $ 1,192,408

Accrued Liabilities (Tables)

Accrued Liabilities (Tables)	9 Months Ended
Accrued Liabilities (Tables)	Sep. 27, 2019
Accrued Liabilities [Abstract]
Schedule of Accrued Liabilities [Table Text Block]	Accrued liabilities in the Condensed Consolidated Balance Sheets consisted of the following: September 27, 2019 December 31, 2018 (In thousands) Accrued compensation and related benefits $ 98,623 $ 72,216 Accrued taxes 49,325 55,554 Accrued asbestos-related liability 63,339 56,045 Warranty liability - current portion 15,899 12,312 Accrued restructuring liability - current portion 7,857 5,475 Accrued third-party commissions 27,607 15,765 Lease liability - current portion 36,761 — Accrued interest 14,551 2,956 Other 117,371 53,694 Accrued liabilities $ 431,333 $ 274,017
Schedule of Product Warranty Liability [Table Text Block]	The activity in the Company’s warranty liability consisted of the following: Nine Months Ended September 27, 2019 September 28, 2018 (In thousands) Warranty liability, beginning of period $ 12,312 $ 10,949 Accrued warranty expense 5,456 5,456 Changes in estimates related to pre-existing warranties 1,256 1,171 Cost of warranty service work performed (7,783 ) (5,900 ) Acquisition-related liability 5,356 — Foreign exchange translation effect (427 ) (478 ) Warranty liability, end of period $ 16,170 $ 11,198
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Condensed Consolidated Balance Sheets is as follows: Nine Months Ended September 27, 2019 Balance at Beginning of Period Acquisitions Provisions Payments Foreign Currency Translation Balance at End of Period (3) (In thousands) Restructuring and other related charges: Fabrication Technology: Termination benefits (1) $ 5,494 $ — $ 6,414 $ (8,051 ) $ (454 ) $ 3,403 Facility closure costs (2) 662 — 5,849 (6,475 ) 27 63 Fabrication Technology subtotal 6,156 — 12,263 (14,526 ) (427 ) 3,466 Non-cash charges (2) 702 12,965 Medical Technology: Termination benefits (1) — 6,096 4,734 (5,723 ) — 5,107 Facility closure costs (2) — — 33,026 (21,640 ) — 11,386 Medical Technology subtotal — 6,096 37,760 (27,363 ) — 16,493 Total $ 6,156 $ 6,096 $ 50,023 $ (41,889 ) $ (427 ) $ 19,959 Non-cash charges (2) 702 $ 50,725 (1) Includes severance and other termination benefits, including outplacement services. (2) Includes the cost of relocating associates, relocating equipment and lease termination expense in connection with the closure of facilities. During the nine months ended September 27, 2019 , the Company recorded an $0.7 million non-cash impairment charge for facilities in the Fabrication Technology segment as part of Corporate approved restructuring activities. Restructuring charges in the Medical Technology segment during the nine months ended September 27, 2019 includes costs related to product and distribution channel transformations, facilities optimization, and integration charges. Restructuring charges in the Medical Technology segment also includes $3.5 million classified as Cost of sales on the Company’s Condensed Consolidated Statements of Operations for the nine months ended September 27, 2019 . (3) As of September 27, 2019 , $7.9 million and $0.7 million of the Company’s restructuring liability was included in Accrued liabilities and Other liabilities, respectively, and $11.4 million was included in Accounts payable.

Net Periodic Benefit Cost-Def_2

Net Periodic Benefit Cost-Defined Benefit Plans (Tables)	9 Months Ended
Net Periodic Benefit Cost-Defined Benefit Plans (Tables)	Sep. 27, 2019
Retirement Benefits [Abstract]
Schedule of Net Benefit Costs [Table Text Block]	The following table sets forth the components of total net periodic benefit cost of the Company’s defined benefit pension plans and other post-retirement employee benefit plans: Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (In thousands) Pension Benefits - U.S. Plans: Service cost $ 33 $ 20 $ 101 101 Interest cost 1,798 1,155 5,393 4,776 Expected return on plan assets (2,660 ) (2,969 ) (7,980 ) (8,247 ) Amortization 776 606 2,327 2,434 Net periodic benefit income $ (53 ) $ (1,188 ) $ (159 ) $ (936 ) Pension Benefits - Non-U.S. Plans: Service cost $ 427 $ 407 $ 1,105 $ 1,154 Interest cost 2,176 2,928 6,705 9,088 Expected return on plan assets (2,181 ) (3,263 ) (6,739 ) (10,139 ) Settlement loss 33,616 — 33,616 — Amortization 102 259 287 801 Net periodic benefit cost $ 34,140 $ 331 $ 34,974 $ 904 Other Post-Retirement Benefits: Service cost $ 1 $ 6 $ 4 $ 19 Interest cost 122 124 366 370 Amortization (37 ) (22 ) (112 ) (66 ) Net periodic benefit cost $ 86 $ 108 $ 258 $ 323 During the three months ended September 27, 2019 , the Company settled a non-U.S. pension plan in its Fabrication Technology segment through a third-party buyout arrangement. As a result of the settlement, the Company is no longer responsible for any liabilities under the plan and recognized a loss of $33.6 million , which is reflected in Pension settlement loss in the Consolidated Statements of Operations.

Financial Instruments and Fai_2

Financial Instruments and Fair Value Measurements (Tables)	9 Months Ended
Financial Instruments and Fair Value Measurements (Tables)	Sep. 27, 2019
Financial Instruments and Fair Value Measurements [Abstract]
Company's assets and liabilities measured at fair value for each fair value hierarchy level [Table Text Block]	A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows: September 27, 2019 Level Level Level Total (In thousands) Assets: Cash equivalents $ 17,740 $ — $ — $ 17,740 Foreign currency contracts related to sales - not designated as hedges — 378 — 378 Foreign currency contracts related to purchases - not designated as hedges — 527 — 527 Deferred compensation plans — 8,297 — 8,297 $ 17,740 $ 9,202 $ — $ 26,942 Liabilities: Foreign currency contracts related to sales - not designated as hedges $ — $ 23 $ — $ 23 Foreign currency contracts related to purchases - not designated as hedges — 809 — 809 Deferred compensation plans — 8,297 — 8,297 $ — $ 9,129 $ — $ 9,129 December 31, 2018 Level Level Level Total (In thousands) Assets: Cash equivalents $ 5,388 $ — $ — $ 5,388 Foreign currency contracts related to sales - not designated as hedges — 326 — 326 Foreign currency contracts related to purchases - not designated as hedges — 325 — 325 Deferred compensation plans — 7,154 — 7,154 $ 5,388 $ 7,805 $ — $ 13,193 Liabilities: Foreign currency contracts related to sales - not designated as hedges $ — $ 133 $ — $ 133 Foreign currency contracts related to purchases - not designated as hedges — 557 — 557 Deferred compensation plans — 7,154 — 7,154 $ — $ 7,844 $ — $ 7,844 There were no transfers in or out of Level One, Two or Three during the nine months ended September 27, 2019
Schedule of Foreign Exchange Contracts, Notional Values	As of September 27, 2019 and December 31, 2018 , the Company had foreign currency contracts with the following notional values: September 27, 2019 December 31, 2018 (In thousands) Foreign currency contracts sold - not designated as hedges $ 24,868 $ 43,510 Foreign currency contracts purchased - not designated as hedges 90,992 75,102 Total foreign currency derivatives $ 115,860 $ 118,612
Schedule of Derivative Instruments, Gain (Loss) in Condensed Consolidated Financial Statements [Table Text Block]	The Company recognized the following in its Condensed Consolidated Financial Statements related to its derivative instruments: Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (In thousands) Contracts Designated as Hedges: Unrealized gain on net investment hedges (1) $ 12,807 $ 671 $ 14,258 $ 9,210 Contracts Not Designated in a Hedge Relationship: Foreign Currency Contracts - related to customer sales contracts: Unrealized gain (loss) 423 (476 ) 215 1,173 Realized loss (165 ) (596 ) (1,232 ) (49 ) Foreign Currency Contracts - related to supplier purchases contracts: Unrealized (loss) gain (732 ) 174 (81 ) (1,631 ) Realized gain 1 397 455 73 (1)

Commitments and Contingencies_2

Commitments and Contingencies (Tables)	9 Months Ended
Commitments and Contingencies (Tables)	Sep. 27, 2019
Commitments and Contingencies Disclosure [Abstract]
Schedule Of Loss Contingencies By Claims Quantities [Table Text Block]	Claims activity since December 31 related to asbestos claims is as follows: Nine Months Ended September 27, 2019 September 28, 2018 (Number of claims) Claims unresolved, beginning of period 16,417 17,737 Claims filed (1) 3,360 2,982 Claims resolved (2) (3,604 ) (4,450 ) Claims unresolved, end of period 16,173 16,269 (1) Claims filed include all asbestos claims for which notification has been received or a file has been opened. (2) Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants.
Schedule Of Asbestos Related Litigation [Table Text Block]	The Company’s Condensed Consolidated Balance Sheets included the following amounts related to asbestos-related litigation: September 27, 2019 December 31, 2018 (In thousands) Current asbestos insurance receivable (1) $ 24,826 $ — Long-term asbestos insurance asset (2) 271,095 278,662 Long-term asbestos insurance receivable (2) 43,802 62,523 Accrued asbestos liability (3) 63,339 56,045 Long-term asbestos liability (4) 268,675 288,962 (1) Included in Other current assets in the Condensed Consolidated Balance Sheets. (2) Included in Other assets in the Condensed Consolidated Balance Sheets. (3) Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay, and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Condensed Consolidated Balance Sheets. (4) Included in Other liabilities in the Condensed Consolidated Balance Sheets.

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
Segment Information (Tables)	Sep. 27, 2019
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	The Company’s segment results were as follows: Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (In thousands) Net sales: Fabrication Technology $ 539,228 $ 524,022 $ 1,692,347 $ 1,618,152 Medical Technology 307,291 — 746,738 — $ 846,519 $ 524,022 $ 2,439,085 $ 1,618,152 Segment operating income (1) : Fabrication Technology $ 72,999 $ 55,634 $ 224,574 $ 190,864 Medical Technology 22,456 — 37,743 — Corporate and other (14,285 ) (13,919 ) (99,864 ) (46,453 ) $ 81,170 $ 41,715 $ 162,453 $ 144,411 (1) Following is a reconciliation of Income (loss) from continuing operations before income taxes to segment operating income: Three Months Ended Nine Months Ended September 27, 2019 September 28, 2018 September 27, 2019 September 28, 2018 (In thousands) Income (loss) from continuing operations before income taxes $ 2,417 $ 23,445 $ (8,708 ) $ 81,185 Loss on short-term investments — — — 10,128 Pension settlement loss 33,616 — 33,616 — Interest expense, net 31,828 11,611 86,820 33,455 Restructuring and other related charges (1) 13,309 6,659 50,725 19,643 Segment operating income $ 81,170 $ 41,715 $ 162,453 $ 144,411

General General (Details)

General General (Details) - USD ($) $ in Millions	Feb. 22, 2019	Sep. 30, 2019
DJO Acquisition [Member]
Business Acquisition [Line Items]
Purchase price for Merger Agreement	$ 3,150
Air and Gas Handling Business [Member] \| Subsequent event
Business Acquisition [Line Items]
Total consideration		$ 1,800
Cash consideration received		$ 1,670

Recently Issued Accounting Pr_2

Recently Issued Accounting Pronouncements Details Textual (Details) - USD ($) $ in Thousands	Sep. 27, 2019	Jan. 01, 2019	Dec. 31, 2018	Dec. 31, 2017
Lease asset - right of use	$ 159,999	$ 153,900	$ 0
Present value of lease liabilities	$ 159,999	153,900
Retained Earnings
Cumulative Effect of New Accounting Principle in Period of Adoption		(15,400)	(15,368)	$ (5,152)
Accumulated Other Comprehensive Loss
Cumulative Effect of New Accounting Principle in Period of Adoption		$ 15,400	$ 15,368	$ 5,152

Discontinued Operations - Effec

Discontinued Operations - Effect on Income Statement and Balance Sheet (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 27, 2019	Sep. 28, 2018	Sep. 27, 2019	Sep. 28, 2018	Dec. 31, 2018
Disposal Group, Including Discontinued Operations, Statement of Income
Held for sale impairment loss			$ 481,000	$ 0
Income (loss) from discontinued operations, net of taxes	$ 9,024	$ 18,544	(486,265)	20,762
ASSETS HELD FOR SALE
Cash and cash equivalents	39,695		39,695		$ 167,866
Trade receivables, less allowance for doubtful accounts of $8,783 and $8,308	520,379		520,379		602,830
Inventories, net	155,877		155,877		136,880
Other current assets	61,079		61,079		89,668
Property, plant, and equipment, net	184,035		184,035		176,189
Goodwill	599,544		599,544		1,078,785
Intangible assets, net	365,728		365,728		384,613
Other assets	110,508		110,508		101,118
Valuation allowance on assets held for sale	(23,500)		(23,500)		0
Total assets held for sale	2,013,345		2,013,345		2,737,949
Less: current portion	2,013,345		2,013,345		997,244
Total assets held for sale, less current portion	0		0		1,740,705
LIABILITIES HELD FOR SALE
Current portion of long-term debt	1,137		1,137		1,314
Accounts payable	256,955		256,955		349,434
Customer advances and billings in excess of costs incurred	158,324		158,324		130,480
Accrued liabilities	140,354		140,354		131,020
Other liabilities	94,948		94,948		95,395
Total liabilities held for sale	651,718		651,718		707,643
Less: current portion	651,718		651,718		612,248
Total liabilities held for sale, less current portion	0		0		95,395
Air and Gas Handling Business [Member]
Disposal Group, Including Discontinued Operations, Statement of Income
Disposal Group, Including Discontinued Operation, Revenue	338,885	351,351	998,793	1,063,434	$ 1,473,700
Disposal Group, Including Discontinued Operation, Costs of Goods Sold	230,692	251,695	689,004	782,232
Selling, general and administrative expense	65,117	65,275	194,562	196,766
Divestiture-related expense, net	4,987	9,257	13,354	21,148
Held for sale impairment loss	0
Restructuring and other related items-discontinued operations	4,481	0	11,692	0
Disposal Group, Including Discontinued Operation, Operating Income (Loss)	33,608	25,124	(390,819)	63,288
Disposal Group, Including Discontinued Operation, Interest Income	12,779	(1,726)	38,899	(4,302)
Disposal Group, Including Discontinued Operation, Pension Settlement Gain (Loss)	0	0	43,774	0
Discontinued operation, loss on discontinued operations		0	481,000	0
Income (loss) from discontinued operations before income taxes	20,829	26,850	(473,492)	67,590
Income tax expense	9,809	5,610	5,387	15,566
Income (loss) from discontinued operations, net of taxes	11,020	21,240	(478,879)	52,024
LIABILITIES HELD FOR SALE
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest	1,500	3,500	5,900	10,000
Fluid Handling Business [Member]
Disposal Group, Including Discontinued Operations, Statement of Income
Selling, general and administrative expense	2,637	2,668	7,645	7,262
Restructuring and other related items-discontinued operations	0	1,013	0	3,371
Disposal Group, Including Discontinued Operation, Operating Income (Loss)	(2,637)	(3,681)	(7,645)	(10,633)
Discontinued operation, loss on discontinued operations	0	0	0	(4,337)
Income (loss) from discontinued operations before income taxes	(2,637)	(3,681)	(7,645)	(14,970)
Income tax expense	(641)	(985)	(259)	16,292
Income (loss) from discontinued operations, net of taxes	$ (1,996)	$ (2,696)	$ (7,386)	$ (31,262)

Discontinued Operations - Narra

Discontinued Operations - Narratives (Details) - USD ($) $ in Thousands	Dec. 11, 2017	Sep. 27, 2019	Sep. 28, 2018	Jun. 29, 2018	Sep. 27, 2019	Sep. 28, 2018	Dec. 31, 2018	Sep. 30, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Held for sale impairment loss					$ 481,000	$ 0
Disposal Group, Including Discontinued Operation, Valuation Allowance		$ 23,500			23,500		$ 0
Shares Received As Compensation For Divestiture, Value	3,300,000
Gain (Loss) on Investments		0	$ 0		0	(10,128)
Air and Gas Handling Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues		338,885	351,351		998,793	1,063,434	$ 1,473,700
Discontinued operation, loss on discontinued operations			0		(481,000)	0
Held for sale impairment loss		0
Disposal Group, Including Discontinued Operation, Other Comprehensive Income (Loss)					(350,000)
Valuation reduction for amounts paid		8,500
Disposal Group, Including Discontinued Operation, Other Comprehensive Income (Loss)		1,500	3,500		5,900	10,000
Cash Provided by (Used in) Operating Activities, Discontinued Operations					18,000	71,700
Cash Used in Investing Activities, Discontinued Operations					(27,500)
Cash Provided by Investing Activities, Discontinued Operations						35,300
Fluid Handling Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Discontinued operation, loss on discontinued operations		$ 0	$ 0		0	$ 4,337
Payments for asset acquisition	$ 860,600
Proceeds from Divestiture of Businesses	551,000
Debt Assumed In Sales Of Business	$ 168,000
CIRCOR
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from Sale of Debt and Equity Securities, FV-NI, Held-for-investment				$ 139,500
Expense Related to Distribution or Servicing and Underwriting Fees				$ 5,800
Goodwill [Member] \| Air and Gas Handling Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Held for sale impairment loss					449,000
Impairment of Long-lived Assets [Member] \| Air and Gas Handling Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Held for sale impairment loss					$ 32,000
Subsequent event \| Air and Gas Handling Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total consideration								$ 1,800,000
Cash consideration received								$ 1,670,000

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) - DJO Acquisition [Member] employee in Thousands, $ in Millions	Feb. 22, 2019USD ($)employeelocation	Sep. 27, 2019USD ($)	Sep. 27, 2019USD ($)
Business Acquisition [Line Items]
Purchase price for Merger Agreement	$ 3,150
Employees \| employee	5
Locations \| location	18
Professional Fees		$ 0.7	$ 56.7
Accrued Liabilities [Member]
Business Acquisition [Line Items]
Professional Fees			$ 0.8

Acquisitions - Proforma Financi

Acquisitions - Proforma Financial Information (Details) - DJO Acquisition [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 27, 2019	Sep. 28, 2018	Sep. 27, 2019	Sep. 28, 2018
Business Acquisition [Line Items]
Net sales	$ 846,519	$ 818,073	$ 2,608,251	$ 2,509,669
Net income (loss) from continuing operations attributable to Colfax Corporation	$ 7,676	$ (3,025)	$ 72,857	$ 39,582

Acquisitions - Fair Value of As

Acquisitions - Fair Value of Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Sep. 27, 2019	Feb. 22, 2019	Dec. 31, 2018
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill [Abstract]		$ 1,737,000
Goodwill	$ 2,784,249		$ 1,497,832
DJO Acquisition [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill [Abstract]		1,737,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables		160,234
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory		208,619
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment		170,601
Goodwill		1,301,451
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable		(108,540)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities		(337,402)
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net		3,131,963
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest		(1,861)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net		$ 3,130,102

Acquisitions - Preliminary Asse

Acquisitions - Preliminary Assets Acquired (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 27, 2019	Feb. 22, 2019
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill [Abstract]		$ 1,737,000
Trademarks [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill [Abstract]		479,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	16 years
Customer Relationships [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill [Abstract]		954,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	14 years
Technology-Based Intangible Assets [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill [Abstract]		$ 304,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	12 years

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 27, 2019	Sep. 28, 2018	Sep. 27, 2019	Sep. 28, 2018
Revenue from Contract with Customer, Excluding Assessed Tax	$ 539,228	$ 524,022	$ 1,692,347	$ 1,618,152
Medical Technology
Revenue from Contract with Customer, Excluding Assessed Tax	307,291		746,738
Equipment
Revenue from Contract with Customer, Excluding Assessed Tax	162,531	143,130	525,148	441,994
Prevention & Rehabilitation \| Medical Technology
Revenue from Contract with Customer, Excluding Assessed Tax	221,314		533,986
Reconstructive \| Medical Technology
Revenue from Contract with Customer, Excluding Assessed Tax	85,977		212,752
Consumables
Revenue from Contract with Customer, Excluding Assessed Tax	$ 376,697	$ 380,892	$ 1,167,199	$ 1,176,158

Revenue - Narrative (Details)

Revenue - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Revenue - Narrative (Details) - USD ($) $ in Millions	Sep. 27, 2019	Sep. 28, 2018	Sep. 27, 2019	Sep. 28, 2018	Dec. 31, 2018	Dec. 31, 2017
Revenue [Abstract]
Contract liability	$ 15.6	$ 19.5	$ 15.6	$ 19.5	$ 13	$ 17.3
Revenue recognized, contract liability	$ 4.8	$ 0.9	$ 13	$ 17.3

Net Income Per Share (Details)

Net Income Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				9 Months Ended
	Sep. 27, 2019		Sep. 28, 2018		Sep. 27, 2019	Sep. 28, 2018
Earnings Per Share [Abstract]
Net income from continuing operations attributable to Colfax Corporation	$ 2,901	[1]	$ 16,231	[1]	$ (18,636)	$ 83,520
Weighted-average shares of Common stock outstanding - basic	136,121,017		117,709,725		135,440,566	121,283,339
Net effect of potentially dilutive securities - stock options and restricted stock units	929,143		747,211		0	518,179
Weighted-average shares of Common stock outstanding - diluted	137,050,160		118,456,936		135,440,566	121,801,518
Net income (loss) per share from continuing operations - diluted	$ 0.02		$ 0.14		$ (0.14)	$ 0.69
Net income (loss) from continuing operations, tax	$ 900		$ 400		$ 3,100	$ 1,700

[1]	Net income (loss) from continuing operations attributable to Colfax Corporation for the respective periods is calculated using Net income (loss) from continuing operations less the continuing operations component of the income attributable to noncontrolling interest, net of taxes of $0.9 million and $3.1 million for the three and nine months ended September 27, 2019 and $0.4 million and $1.7 million for the three and nine months ended September 28, 2018 , respectively.

Net Income Per Share (Details T

Net Income Per Share (Details Textual) - shares shares in Millions	3 Months Ended		9 Months Ended
	Sep. 27, 2019	Sep. 28, 2018	Sep. 27, 2019
Earnings Per Share, Basic
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	4.4	3.5	4.6
Tangible Equity Unit [Member]
Earnings Per Share, Basic
Weighted Average Number Of Shares Outstanding, Tangible Equity Units, Basic	18.4

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Sep. 27, 2019	Sep. 28, 2018	Sep. 27, 2019	Sep. 28, 2018
Income Tax Disclosure [Abstract]
Income (loss) from continuing operations before income taxes	$ 2,417	$ 23,445	$ (8,708)	$ 81,185
(Benefit) provision for income taxes	$ (1,353)	$ 6,787	$ 6,840	$ (4,076)
Effective tax rate	(56.00%)	28.90%	(78.50%)	(5.00%)
Nondeductible deal costs			$ 16,700
Tax expense due to change in valuation allowance due to business acquisition			$ 9,200
Discrete tax benefit		$ 4,400		$ 29,800

Equity (Details - AOCI Componen

Equity (Details - AOCI Components) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
Equity (Details - AOCI Components) - USD ($) $ in Thousands		Sep. 27, 2019	Sep. 28, 2018	Sep. 27, 2019	Sep. 28, 2018	Dec. 31, 2018
Changes in Accumulated Other Comprehensive Loss [Line Items]
Beginning Balance				$ (780,177)
Beginning Balance, adjusted for change of accounting principle						$ (795,545)
Foreign currency translation adjustment				(120,167)	$ (172,672)
Loss on long-term intra-entity foreign currency transactions				(4,197)	6,777
Loss on net investment hedges				14,258	9,210
Unrealized gain on cash flow hedges				167	(2,191)
Other comprehensive income (loss) before reclassifications				(109,939)	(158,876)
Amounts reclassified from Accumulated other comprehensive loss				(22,704)	2,506
Noncontrolling interest share repurchase				20,962
Net current period other comprehensive income (loss)				(153,605)	(156,370)
Ending Balance		$ (949,150)	$ (735,894)	(949,150)	(735,894)
Net Unrecognized Pension And Other Post-Retirement Benefit Cost [Member]
Changes in Accumulated Other Comprehensive Loss [Line Items]
Beginning Balance				(80,794)
Foreign currency translation adjustment				859	835
Loss on long-term intra-entity foreign currency transactions				0	0
Loss on net investment hedges				0	0
Unrealized gain on cash flow hedges				0	0
Other comprehensive income (loss) before reclassifications				859	835
Amounts reclassified from Accumulated other comprehensive loss				(22,704)	2,506
Noncontrolling interest share repurchase				0
Net current period other comprehensive income (loss)				(21,845)	3,341
Ending Balance		(102,639)	(80,997)	(102,639)	(80,997)
Foreign Currency Translation Adjustment [Member]
Changes in Accumulated Other Comprehensive Loss [Line Items]
Beginning Balance				(752,989)
Foreign currency translation adjustment				(120,722)	(173,041)
Loss on long-term intra-entity foreign currency transactions				(4,197)	6,777
Loss on net investment hedges				0	0
Unrealized gain on cash flow hedges				0	0
Other comprehensive income (loss) before reclassifications				(124,919)	(166,264)
Amounts reclassified from Accumulated other comprehensive loss				0	0
Noncontrolling interest share repurchase				20,962
Net current period other comprehensive income (loss)				(145,881)	(166,264)
Ending Balance		(898,870)	(691,588)	(898,870)	(691,588)
Unrealized Gain On Hedging Activities [Member]
Changes in Accumulated Other Comprehensive Loss [Line Items]
Beginning Balance				38,238
Foreign currency translation adjustment				(304)	(466)
Loss on long-term intra-entity foreign currency transactions				0	0
Loss on net investment hedges					9,210
Unrealized gain on cash flow hedges				167	(2,191)
Other comprehensive income (loss) before reclassifications				14,121	6,553
Amounts reclassified from Accumulated other comprehensive loss				0	0
Noncontrolling interest share repurchase				0
Net current period other comprehensive income (loss)				14,121	6,553
Ending Balance		52,359	36,691	52,359	$ 36,691
Designated As Hedging Instrument
Changes in Accumulated Other Comprehensive Loss [Line Items]
Loss on net investment hedges	[1]		$ 671
Designated As Hedging Instrument \| Unrealized Gain On Hedging Activities [Member]
Changes in Accumulated Other Comprehensive Loss [Line Items]
Loss on net investment hedges		$ 12,807		$ 14,258

[1]	The unrealized gain on net investment hedges is attributable to the change in valuation of Euro denominated debt.

Equity Equity Textual (Details)

Equity Equity Textual (Details) - USD ($)	Jan. 11, 2019	Sep. 27, 2019	Apr. 15, 2019	Jul. 19, 2018	Jun. 06, 2018	Feb. 12, 2018
Gross proceeds	$ 460,000,000	$ 460,000,000
Tangible Equity Units Issued, Number	4,000,000
Tangible Equity Units Issued, State Rate Of Return	5.75%	6.50%
Tangible Equity Unit, Quarterly Cash Distribution		$ 1.4375	$ 1.5014
Tangible Equity Unit, Quarterly Cash Distribution, Percentage		5.75%
Fair value per unit	$ 100
Tangible Equity Unit, Repayment		$ 13,500,000
Stock Purchase Contracts Outstanding		4,600,000
Tangible Equity Units Issued, Number, Additional Issuable	600,000
Tangible Equity Units Issued, Cash Proceeds	$ 447,700,000
Prepaid Stock Purchase Contracts, Fair Value		$ 377,800,000
Tangible Equity Units Issued, Fair Value		69,900,000
Tangible Equity Units Issued, Noncurrent		47,300,000
Tangible Equity Units Issued, Current		$ 22,600,000
Tangible Equity Unit, Reference Price		$ 20.81
Tangible Equity Unit, Threshold Appreciation Price		25
Tangible Equity Unit, Initial Principal Amount		$ 15.6099
Stock Repurchase Program, Authorized Amount				$ 100,000,000	$ 100,000,000	$ 100,000,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount		$ 100,000,000
Minimum [Member]
Shares Issued per Purchase Contract		4
Tangible Equity Units, Threshold For Conversion		18,400,000
Maximum [Member]
Shares Issued per Purchase Contract		4.8054
Tangible Equity Units, Threshold For Conversion		22,100,000

Equity - Schedule of TEUs (Deta

Equity - Schedule of TEUs (Details) - USD ($) $ / shares in Units, $ in Millions	Jan. 11, 2019	Sep. 27, 2019
Class of Stock [Line Items]
Fair value per unit	$ 100
Gross proceeds	$ 460	$ 460
Less: Issuance costs		12.3
Net proceeds		447.7
TEU prepaid stock purchase contracts
Class of Stock [Line Items]
Fair value per unit	$ 84.39
Gross proceeds		388.2
Less: Issuance costs		10.4
Net proceeds		377.8
TEU amortizing notes
Class of Stock [Line Items]
Fair value per unit	$ 15.61
Gross proceeds		71.8
Less: Issuance costs		1.9
Net proceeds		$ 69.9

Inventories, Net (Details)

Inventories, Net (Details) - USD ($) $ in Thousands	Sep. 27, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Raw materials	$ 121,930	$ 120,383
Work in process	41,777	27,834
Finished goods	482,631	245,571
Inventory, gross	646,338	393,788
Less: allowance for excess, slow-moving and obsolete inventory	(61,987)	(34,133)
Inventories, net	$ 584,351	$ 359,655

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	9 Months Ended
Leases (Details) - USD ($) $ in Thousands	Sep. 27, 2019	Jan. 01, 2019
Leases [Abstract]
Operating lease expense	$ 28,340
2019	10,468
2020	38,244
2021	30,100
2022	22,416
2023	18,584
Thereafter	65,238
Total	185,050
Less: present value discount	(25,051)
Present value of lease liabilities	$ 159,999	$ 153,900
Weighted-average remaining lease term (in years):	8 years 1 month 6 days
Weighted-average discount rate:	3.50%

Debt Components (Details)

Debt Components (Details) - USD ($) $ in Thousands	Sep. 27, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Total Debt	$ 4,032,019	$ 1,197,428
Less: current portion	(29,654)	(5,020)
Long-term debt	4,002,365	1,192,408
Term Loan [Member]
Debt Instrument [Line Items]
Total Debt	1,675,826	485,959
Revolving credit facilities and other [Member]
Debt Instrument [Line Items]
Total Debt	928,996	316,049
Euro Senior Notes [Member]
Debt Instrument [Line Items]
Total Debt	379,030	395,420
TEU Amortizing Notes [Member]
Debt Instrument [Line Items]
Total Debt	59,452	0
2024 And 2026 Notes [Member]
Debt Instrument [Line Items]
Total Debt	$ 988,715	$ 0

Debt (Details Textual)

Debt (Details Textual) $ / shares in Units, € in Millions, $ in Millions	Feb. 05, 2019USD ($)	Jan. 11, 2019USD ($)$ / sharesshares	Dec. 17, 2018USD ($)	Apr. 19, 2017EUR (€)	Oct. 31, 2019USD ($)	Sep. 27, 2019USD ($)	Apr. 19, 2017USD ($)
Repayment of a portion of Term Loan Facilities and Revolver \| €				€ 283.5
Gross proceeds		$ 460				$ 460
Tangible Equity Units Issued, Number \| shares		4,000,000
Interest Rate of Tangible Equity Notes		5.75%				6.50%
Fair value per unit \| $ / shares		$ 100
Tangible Equity Units Issued, Cash Proceeds		$ 447.7
Proceeds from Sale of Tangible Equity Units Prepaid Stock Purchase Contracts		377.8
Proceeds from Sale of Tangible Equity Units Senior Amortizing Notes		$ 69.9
Tangible Equity Units Issued, Number, Additional Issuable \| shares		600,000
Letter of Credit Subfacility, Maximum Borrowing Capacity						$ 498.2
Letters of Credit, Amount Outstanding						57.8
Debt Instrument, Unamortized Discount						$ 26.7
2024 Notes [Member]
Proceeds from borrowings on senior unsecured notes	$ 600
Debt Instrument, Interest Rate, Stated Percentage	6.00%
2026 Notes [Member]
Proceeds from borrowings on senior unsecured notes	$ 400
Debt Instrument, Interest Rate, Stated Percentage	6.375%
DB credit agreement [Member]
Long-term Debt, Weighted Average Interest Rate						4.22%
Line of Credit Facility, Remaining Borrowing Capacity						$ 415
Senior Notes [Member]
Proceeds from borrowings on senior unsecured notes \| €				€ 350
Euro Bond Coupon Rate						3.25%
Deferred Finance Costs, Net							$ 6
Bilateral agreements [Member]
Long-term Debt, Weighted Average Interest Rate						3.75%
Line of Credit Facility, Maximum Borrowing Capacity						$ 267.4
Outstanding borrowings						35
New Revolving Credit Facility [Member]
Interest Income (Expense), Net						0.8
Deferred Finance Costs, Net						$ 12.8
New Revolving Credit Facility [Member] \| DJO Global Inc Financing Facilities [Member]
Line of Credit Facility Capacity Available for Specific Future Transaction			$ 1,300
Line of Credit Sub Facility Maximum Borrowing Capacity Available for Specific Future Transaction			50
Debt Instrument Covenant Initial Maximum Total Leverage Ratio						6
Debt Instrument Covenant Minimum Interest Coverage Ratio						3
Debt Instrument Covenant Springing Collateral Provision Minimum Total Leverage Ratio						3.75
New Revolving Credit Facility [Member] \| Term A1 Loan [Member]
Debt Instrument Available for Specific Future Transaction Term A1 Loan			1,200
New Revolving Credit Facility [Member] \| Term A2 Loan [Member]
Debt Instrument Available for Specific Future Transaction Term A2 Loan			$ 500
Eurodollar [Member] \| New Revolving Credit Facility [Member] \| DJO Global Inc Financing Facilities [Member]
Debt Instrument, Basis Spread on Variable Rate			1.75%
Base Rate [Member] \| New Revolving Credit Facility [Member] \| DJO Global Inc Financing Facilities [Member]
Debt Instrument, Basis Spread on Variable Rate			0.75%
Minimum [Member] \| Eurodollar [Member] \| New Revolving Credit Facility [Member] \| DJO Global Inc Financing Facilities [Member]
Debt Instrument, Basis Spread on Variable Rate			1.25%
Minimum [Member] \| Base Rate [Member] \| New Revolving Credit Facility [Member] \| DJO Global Inc Financing Facilities [Member]
Debt Instrument, Basis Spread on Variable Rate			0.25%
Maximum [Member] \| Eurodollar [Member] \| New Revolving Credit Facility [Member] \| DJO Global Inc Financing Facilities [Member]
Debt Instrument, Basis Spread on Variable Rate			2.00%
Maximum [Member] \| Base Rate [Member] \| New Revolving Credit Facility [Member] \| DJO Global Inc Financing Facilities [Member]
Debt Instrument, Basis Spread on Variable Rate			1.00%
Step Down at the End of the Second and Third Fiscal Quarters Following Consummation of Acquisition [Member] \| New Revolving Credit Facility [Member] \| DJO Global Inc Financing Facilities [Member]
Debt Instrument Covenant Step Down Maximum Total Leverage Ratio						5.50
Step Down at the End of the Fourth and Fifth Fiscal Quarters Following Consummation of Acquisition [Member] \| New Revolving Credit Facility [Member] \| DJO Global Inc Financing Facilities [Member]
Debt Instrument Covenant Step Down Maximum Total Leverage Ratio						4.75
Step Down at the End of the Sixth Fiscal Quarter Following Consummation of Acquisition [Member] \| New Revolving Credit Facility [Member] \| DJO Global Inc Financing Facilities [Member]
Debt Instrument Covenant Step Down Maximum Total Leverage Ratio						4.25
Step Down at the End of the Seventh Fiscal Quarter Following Consummation of Acquisition [Member] \| New Revolving Credit Facility [Member] \| DJO Global Inc Financing Facilities [Member]
Debt Instrument Covenant Step Down Maximum Total Leverage Ratio						4
Step Down at the End of the Eighth Fiscal Quarter Following Consummation of Acquisition [Member] \| New Revolving Credit Facility [Member] \| DJO Global Inc Financing Facilities [Member]
Debt Instrument Covenant Step Down Maximum Total Leverage Ratio						3.50
Subsequent event
Repayment of a portion of Term Loan Facilities and Revolver					$ 1,650

Accrued Liabilities Chart (Deta

Accrued Liabilities Chart (Details) - USD ($) $ in Thousands		Sep. 27, 2019	Dec. 31, 2018
Accrued Liabilities [Abstract]
Accrued payroll		$ 98,623	$ 72,216
Accrued taxes		49,325	55,554
Accrued asbestos-related liability	[1]	63,339	56,045
Warranty liability - current portion		15,899	12,312
Accrued third-party commissions		27,607	15,765
Operating Lease, Liability, Current		36,761	0
Interest and Dividends Payable, Current		14,551	2,956
Other		117,371	53,694
Accrued liabilities		$ 431,333	$ 274,017

[1]	Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay, and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Condensed Consolidated Balance Sheets.

Warranty Liability Rollforward

Warranty Liability Rollforward (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 27, 2019	Sep. 28, 2018
Movement in Standard Product Warranty Accrual [Roll Forward]
Warranty liability, beginning of period	$ 12,312	$ 10,949
Accrued warranty expense	5,456	5,456
Changes in estimates related to pre-existing warranties	1,256	1,171
Cost of warranty service work performed	(7,783)	(5,900)
Acquisition-related liability	5,356	0
Foreign exchange translation effect	(427)	(478)
Warranty liability, end of period	$ 16,170	$ 11,198

Restructuring Rollforward (Deta

Restructuring Rollforward (Details) $ in Thousands	9 Months Ended
Restructuring Rollforward (Details) $ in Thousands	Sep. 27, 2019USD ($)
Balance at Beginning of Period	$ 6,156
Acquisitions	6,096
Provisions before non-cash charges	50,023
Payments	(41,889)
Foreign Currency Translation	(427)
Balance at End of Period	19,959
Non cash charges	702
Provisions	50,725
Fabrication Technology
Balance at Beginning of Period	6,156
Provisions before non-cash charges	12,263
Payments	(14,526)
Foreign Currency Translation	(427)
Balance at End of Period	3,466
Non cash charges	702
Provisions	12,965
Medical Technology
Balance at Beginning of Period	0
Acquisitions	6,096
Provisions before non-cash charges	37,760
Payments	(27,363)
Foreign Currency Translation	0
Balance at End of Period	16,493
Termination benefits \| Fabrication Technology
Balance at Beginning of Period	5,494
Provisions before non-cash charges	6,414
Payments	(8,051)
Foreign Currency Translation	(454)
Balance at End of Period	3,403
Termination benefits \| Medical Technology
Balance at Beginning of Period	0
Acquisitions	6,096
Provisions before non-cash charges	4,734
Payments	(5,723)
Foreign Currency Translation	0
Balance at End of Period	5,107
Facility closure costs \| Fabrication Technology
Balance at Beginning of Period	662
Provisions before non-cash charges	5,849
Payments	(6,475)
Foreign Currency Translation	27
Balance at End of Period	63
Facility closure costs \| Medical Technology
Balance at Beginning of Period	0
Provisions before non-cash charges	33,026
Payments	(21,640)
Foreign Currency Translation	0
Balance at End of Period	$ 11,386

Accrued Liabilities (Details Te

Accrued Liabilities (Details Textual) - USD ($) $ in Thousands	9 Months Ended
	Sep. 27, 2019	Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]
Asset Impairment Charges	$ 700
Accrued Liabilities [Member]
Restructuring Cost and Reserve [Line Items]
Accrued restructuring liability - current portion	7,857	$ 5,475
Other Noncurrent Liabilities [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Noncurrent	700
Accounts Payable [Member]
Restructuring Cost and Reserve [Line Items]
Accrued restructuring liability - current portion	$ 11,400

Net Periodic Benefit Cost-Def_3

Net Periodic Benefit Cost-Defined Benefit Plans (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 27, 2019	Sep. 28, 2018	Sep. 27, 2019	Sep. 28, 2018
Settlement loss	$ 33,616	$ 0	$ 33,616	$ 0
Pension Plan [Member]
Service cost	33	20	101	101
Interest cost	1,798	1,155	5,393	4,776
Expected return on plan assets	(2,660)	(2,969)	(7,980)	(8,247)
Amortization	776	606	2,327	2,434
Net periodic benefit cost (income)	(53)	(1,188)	(159)	(936)
Pension Benefits - Non-U.S. Plans: [Member]
Service cost	427	407	1,105	1,154
Interest cost	2,176	2,928	6,705	9,088
Expected return on plan assets	(2,181)	(3,263)	(6,739)	(10,139)
Settlement loss	33,616	0		0
Amortization	102	259	287	801
Net periodic benefit cost (income)	34,140	331	34,974	904
Other Post-Retirement Benefits: [Member]
Service cost	1	6	4	19
Interest cost	122	124	366	370
Amortization	(37)	(22)	(112)	(66)
Net periodic benefit cost (income)	$ 86	$ 108	$ 258	$ 323

Financial Instruments and Fai_3

Financial Instruments and Fair Value Measurements (Details) - USD ($) $ in Billions	Sep. 27, 2019	Dec. 31, 2018
Financial Instruments and Fair Value Measurements [Abstract]
Long-term Debt, Fair Value	$ 4	$ 1.2

Fair Value Hierarchy (Details)

Fair Value Hierarchy (Details) - USD ($) $ in Thousands	Sep. 27, 2019	Dec. 31, 2018
Cash equivalents	$ 17,740	$ 5,388
Deferred compensation plans asset	8,297	7,154
Deferred compensation plans liability	8,297	7,154
Assets, Fair Value Disclosure	26,942	13,193
Liabilities, Fair Value Disclosure	9,129	7,844
Fair Value, Inputs, Level 1 [Member]
Cash equivalents	17,740	5,388
Assets, Fair Value Disclosure	17,740	5,388
Fair Value, Inputs, Level 2 [Member]
Deferred compensation plans asset	8,297	7,154
Deferred compensation plans liability	8,297	7,154
Assets, Fair Value Disclosure	9,202	7,805
Liabilities, Fair Value Disclosure	9,129	7,844
Foreign currency contracts related to customer sales contracts
Foreign currency contracts not designated as hedges, Assets	378	326
Foreign currency contracts not designated as hedges, Liability	23	133
Foreign currency contracts related to customer sales contracts \| Fair Value, Inputs, Level 2 [Member]
Foreign currency contracts not designated as hedges, Assets	378	326
Foreign currency contracts not designated as hedges, Liability	23	133
Foreign currency contracts related to supplier purchase contracts
Foreign currency contracts not designated as hedges, Assets	527	325
Foreign currency contracts not designated as hedges, Liability	809	557
Foreign currency contracts related to supplier purchase contracts \| Fair Value, Inputs, Level 2 [Member]
Foreign currency contracts not designated as hedges, Assets	527	325
Foreign currency contracts not designated as hedges, Liability	$ 809	$ 557

Foreign Currency Contracts Noti

Foreign Currency Contracts Notional Values (Details) - USD ($) $ in Thousands	Sep. 27, 2019	Dec. 31, 2018
Derivative, Notional Amount	$ 115,860	$ 118,612
Foreign currency contracts related to customer sales contracts \| Not Designated As Hedging Instrument [Member]
Derivative, Notional Amount	24,868	43,510
Foreign currency contracts related to supplier purchase contracts \| Not Designated As Hedging Instrument [Member]
Derivative, Notional Amount	$ 90,992	$ 75,102

Gain (Loss) On Derivative Instr

Gain (Loss) On Derivative Instruments (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 27, 2019	Sep. 28, 2018	Sep. 27, 2019	Sep. 28, 2018
Unrealized (loss) gain on net investment hedges				$ 14,258	$ 9,210
Designated As Hedging Instrument
Unrealized (loss) gain on net investment hedges	[1]		$ 671
Not Designated As Hedging Instrument [Member] \| Foreign currency contracts related to customer sales contracts
Unrealized gain (loss) on Foreign Currency Contracts		$ 423	(476)	215	1,173
Realized gain (loss) on Foreign Currency Contracts		(165)	(596)	(1,232)	(49)
Not Designated As Hedging Instrument [Member] \| Foreign currency contracts related to supplier purchase contracts
Unrealized gain (loss) on Foreign Currency Contracts		(732)	174	(81)	(1,631)
Realized gain (loss) on Foreign Currency Contracts		$ 1	$ 397	$ 455	$ 73

[1]	The unrealized gain on net investment hedges is attributable to the change in valuation of Euro denominated debt.

Claims Rollforward (Details)

Claims Rollforward (Details) - Asbestos_claims		9 Months Ended
Claims Rollforward (Details) - Asbestos_claims		Sep. 27, 2019	Sep. 28, 2018
Commitments and Contingencies Disclosure [Abstract]
Claims unresolved, beginning of period		16,417	17,737
Claims filed	[1]	3,360	2,982
Claims resolved	[2]	(3,604)	(4,450)
Claims unresolved, end of period		16,173	16,269

[1]	Claims filed include all asbestos claims for which notification has been received or a file has been opened.
[2]	Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants.

Asbestos Litigation (Details 1)

Asbestos Litigation (Details 1) - USD ($) $ in Thousands		Sep. 27, 2019	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Long-term asbestos insurance asset	[1]	$ 271,095	$ 278,662
Long-term asbestos insurance receivable	[1]	43,802	62,523
Accrued asbestos liability	[2]	63,339	56,045
Long-term asbestos liability	[3]	$ 268,675	$ 288,962

[1]	Included in Other assets in the Condensed Consolidated Balance Sheets.
[2]	Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay, and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Condensed Consolidated Balance Sheets.
[3]	Included in Other liabilities in the Condensed Consolidated Balance Sheets.

Segment Information (Details)

Segment Information (Details) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
Segment Information (Details) $ in Thousands	Sep. 27, 2019USD ($)	Sep. 28, 2018USD ($)	Sep. 27, 2019USD ($)segment	Sep. 28, 2018USD ($)	Dec. 31, 2018segment
Number of Operating Segments \| segment			2		3
Revenues	$ 846,519	$ 524,022	$ 2,439,085	$ 1,618,152
Income (loss) from continuing operations before income taxes	2,417	23,445	(8,708)	81,185
Loss on short-term investments	0	0	0	10,128
Interest expense	31,828	11,611	86,820	33,455
Restructuring and other related charges	13,309	6,659	50,725	19,643
Segment Operating Income (Loss)	81,170	41,715	162,453	144,411
Settlement loss	33,616	0	33,616	0
Fabrication Technology
Revenues	539,228	524,022	1,692,347	1,618,152
Segment Operating Income (Loss)	72,999	55,634	224,574	190,864
Medical Technology
Revenues	307,291	0	746,738	0
Segment Operating Income (Loss)	22,456	0	37,743	0
Corporate and other
Segment Operating Income (Loss)	(14,285)	$ (13,919)	(99,864)	$ (46,453)
Cost of Sales [Member]
Restructuring and other related charges	$ 3,500		$ 3,500

Subsequent Events (Details)

Subsequent Events (Details) € in Millions, $ in Millions	Apr. 19, 2017EUR (€)	Oct. 31, 2019USD ($)	Sep. 30, 2019USD ($)
Subsequent Event [Line Items]
Repayment of a portion of Term Loan Facilities and Revolver \| €	€ 283.5
Subsequent event
Subsequent Event [Line Items]
Repayment of a portion of Term Loan Facilities and Revolver		$ 1,650
Air and Gas Handling Business [Member] \| Subsequent event
Subsequent Event [Line Items]
Total consideration			$ 1,800
Cash consideration received			$ 1,670

Uncategorized Items - cfx10q-q3

Label	Element	Value
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax	us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax	$ (525,324,000)
Unrealized Gain (Loss) on Hedging Activities [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax	us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax	30,138,000
Pension and Other Postretirement Benefit Plans Defined Benefit [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax	us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax	$ (84,338,000)